The	O
AD1	B-protein
and	O
AD2	B-protein
transactivation	O
domains	O
of	O
E2A	B-protein
are	O
essential	O
for	O
the	O
antiapoptotic	O
activity	O
of	O
the	O
chimeric	B-protein
oncoprotein	I-protein
E2A-HLF	B-protein
.	O

The	O
chimeric	B-protein
oncoprotein	I-protein
E2A-HLF	B-protein
,	O
generated	O
by	O
the	O
t	B-DNA
(	I-DNA
17	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
chromosomal	I-DNA
translocation	I-DNA
in	O
pro-B-cell	O
acute	O
lymphoblastic	O
leukemia	O
,	O
incorporates	O
the	O
transactivation	B-protein
domains	I-protein
of	O
E2A	B-protein
and	O
the	O
basic	B-protein
leucine	I-protein
zipper	I-protein
(	I-protein
bZIP	I-protein
)	I-protein
DNA-binding	I-protein
and	I-protein
protein	I-protein
dimerization	I-protein
domain	I-protein
of	O
HLF	B-protein
(	O
hepatic	B-protein
leukemic	I-protein
factor	I-protein
)	O
.	O

The	O
ability	O
of	O
E2A-HLF	B-protein
to	O
prolong	O
the	O
survival	O
of	O
interleukin-3	B-cell_line
(	I-cell_line
IL-3	I-cell_line
)	I-cell_line
-dependent	I-cell_line
murine	I-cell_line
pro-B	I-cell_line
cells	I-cell_line
after	O
IL-3	B-protein
withdrawal	O
suggests	O
that	O
it	O
disrupts	O
signaling	O
pathways	O
normally	O
responsible	O
for	O
cell	O
suicide	O
,	O
allowing	O
the	O
cells	O
to	O
accumulate	O
as	O
transformed	B-cell_type
lymphoblasts	I-cell_type
.	O

To	O
determine	O
the	O
structural	O
motifs	O
that	O
contribute	O
to	O
this	O
antiapoptotic	O
effect	O
,	O
we	O
constructed	O
a	O
panel	O
of	O
E2A-HLF	B-protein
mutants	I-protein
and	O
programmed	O
their	O
expression	O
in	O
IL-3-dependent	B-cell_line
murine	I-cell_line
pro-B	I-cell_line
cells	I-cell_line
(	O
FL5.12	B-cell_line
line	I-cell_line
)	O
,	O
using	O
a	O
zinc-inducible	O
vector	O
.	O

Neither	O
the	O
E12	B-protein
nor	O
the	O
E47	B-protein
product	O
of	O
the	O
E2A	B-DNA
gene	I-DNA
nor	O
the	O
wild-type	B-protein
HLF	I-protein
protein	I-protein
was	O
able	O
to	O
protect	O
the	O
cells	O
from	O
apoptosis	O
induced	O
by	O
IL-3	B-protein
deprivation	O
.	O

Surprisingly	O
,	O
different	O
combinations	O
of	O
disabling	O
mutations	O
within	O
the	O
HLF	B-protein
bZIP	I-protein
domain	I-protein
had	O
little	O
effect	O
on	O
the	O
antiapoptotic	O
property	O
of	O
the	O
chimeric	B-protein
protein	I-protein
,	O
so	O
long	O
as	O
the	O
amino-terminal	O
portion	O
of	O
E2A	B-protein
remained	O
intact	O
.	O

In	O
the	O
context	O
of	O
a	O
bZIP	B-protein
domain	I-protein
defective	O
in	O
DNA	O
binding	O
,	O
mutants	O
retaining	O
either	O
of	O
the	O
two	O
transactivation	B-protein
domains	I-protein
of	O
E2A	B-protein
were	O
able	O
to	O
extend	O
cell	O
survival	O
after	O
growth	B-protein
factor	I-protein
deprivation	O
.	O

Thus	O
,	O
the	O
block	O
of	O
apoptosis	O
imposed	O
by	O
E2A-HLF	B-protein
in	O
pro-B	B-cell_type
lymphocytes	I-cell_type
depends	O
critically	O
on	O
the	O
transactivating	B-protein
regions	I-protein
of	O
E2A	B-protein
.	O

Since	O
neither	O
DNA	O
binding	O
nor	O
protein	O
dimerization	O
through	O
the	O
bZIP	B-protein
domain	I-protein
of	O
HLF	B-protein
is	O
required	O
for	O
this	O
effect	O
,	O
we	O
propose	O
mechanisms	O
whereby	O
protein-protein	O
interactions	O
with	O
the	O
amino-terminal	O
region	O
of	O
E2A	B-protein
allow	O
the	O
chimera	B-protein
to	O
act	O
as	O
a	O
transcriptional	O
cofactor	O
to	O
alter	O
the	O
expression	O
of	O
genes	O
regulating	O
the	O
apoptotic	O
machinery	O
in	O
pro-B	B-cell_type
cells	I-cell_type
.	O

MoLECcULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGy	NULL
,	NULL
Oct.	NULL
1998	NULL
,	NULL
p.	NULL
6035-6043	NULL
0270-7306/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

The	NULL
AD1	NULL
and	NULL
AD2	NULL
Transactivation	NULL
Domains	NULL
of	NULL
E2A	NULL
Are	NULL
Essential	NULL
for	NULL
the	NULL
Antiapoptotic	NULL
Activity	NULL
of	NULL
the	NULL
Chimeric	NULL
Oncoprotein	NULL
E2A-HLF	NULL
TAKESHI	NULL
INUKAL	NULL
,	NULL
'¢	NULL
TOSHIYA	NULL
INABA	NULL
,	NULL
*	NULL
SATOSHI	NULL
IKUSHIMA	NULL
,	NULL
'	NULL
#	NULL
anp	NULL
A.	NULL
THOMAS	NULL
LOOK	NULL
!	NULL

***	NULL
Department	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38105	NULL
;	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
329-04	NULL
,	NULL
Japan	NULL
``	NULL
;	NULL
and	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
University	NULL
of	NULL
Tennessee	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Memphis	NULL
,	NULL
Tennessee	NULL
38163°	NULL
Received	NULL
27	NULL
May	NULL
1998/Accepted	NULL
1	NULL
July	NULL
1998	NULL
The	NULL
chimeric	NULL
oncoprotein	NULL
E2A-HLF	NULL
,	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
chromosomal	NULL
translocation	NULL
in	NULL
pro-B-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
,	NULL
incorporates	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
E2A	NULL
and	NULL
the	NULL
basic	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
DNA-binding	NULL
and	NULL
protein	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
(	NULL
hepatic	NULL
leukemic	NULL
factor	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
E2A-HLF	NULL
to	NULL
prolong	NULL
the	NULL
survival	NULL
of	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
-dependent	NULL
murine	NULL
pro-B	NULL
cells	NULL
after	NULL
IL-3	NULL
withdrawal	NULL
suggests	NULL
that	NULL
it	NULL
disrupts	NULL
signaling	NULL
pathways	NULL
normally	NULL
responsible	NULL
for	NULL
cell	NULL
suicide	NULL
,	NULL
allowing	NULL
the	NULL
cells	NULL
to	NULL
accumulate	NULL
as	NULL
transformed	NULL
lymphoblasts	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
structural	NULL
motifs	NULL
that	NULL
contribute	NULL
to	NULL
this	NULL
antiapoptotic	NULL
effect	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
panel	NULL
of	NULL
E2A-HLF	NULL
mutants	NULL
and	NULL
programmed	NULL
their	NULL
expression	NULL
in	NULL
IL-3-dependent	NULL
murine	NULL
pro-B	NULL
cells	NULL
(	NULL
FL5.12	NULL
line	NULL
)	NULL
,	NULL
using	NULL
a	NULL
zinc-inducible	NULL
vector	NULL
.	NULL

Neither	NULL
the	NULL
E12	NULL
nor	NULL
the	NULL
E47	NULL
product	NULL
of	NULL
the	NULL
£24	NULL
gene	NULL
nor	NULL
the	NULL
wild-type	NULL
HLF	NULL
protein	NULL
was	NULL
able	NULL
to	NULL
protect	NULL
the	NULL
cells	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
IL-3	NULL
deprivation	NULL
.	NULL

Surprisingly	NULL
,	NULL
different	NULL
combinations	NULL
of	NULL
disabling	NULL
mutations	NULL
within	NULL
the	NULL
HLF	NULL
bZIP	NULL
domain	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
antiapoptotic	NULL
property	NULL
of	NULL
the	NULL
chimeric	NULL
protein	NULL
,	NULL
so	NULL
long	NULL
as	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
E2A	NULL
remained	NULL
intact	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
a	NULL
bZIP	NULL
domain	NULL
defective	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
mutants	NULL
retaining	NULL
either	NULL
of	NULL
the	NULL
two	NULL
transactivation	NULL
domains	NULL
of	NULL
E2A	NULL
were	NULL
able	NULL
to	NULL
extend	NULL
cell	NULL
survival	NULL
after	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
block	NULL
of	NULL
apoptosis	NULL
imposed	NULL
by	NULL
E2A-HLF	NULL
in	NULL
pro-B	NULL
lymphocytes	NULL
depends	NULL
critically	NULL
on	NULL
the	NULL
transactivating	NULL
regions	NULL
of	NULL
E2A	NULL
.	NULL

Since	NULL
neither	NULL
DNA	NULL
binding	NULL
nor	NULL
protein	NULL
dimerization	NULL
through	NULL
the	NULL
bZIP	NULL
domain	NULL
of	NULL
HLF	NULL
is	NULL
required	NULL
for	NULL
this	NULL
effect	NULL
,	NULL
we	NULL
propose	NULL
mechanisms	NULL
whereby	NULL
protein-protein	NULL
interactions	NULL
with	NULL
the	NULL
amino-terminal	NULL
region	NULL
of	NULL
E2A	NULL
allow	NULL
the	NULL
chimera	NULL
to	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
cofactor	NULL
to	NULL
alter	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
regulating	NULL
the	NULL
apoptotic	NULL
machinery	NULL
in	NULL
pro-B	NULL
cells	NULL
.	NULL

Dysregulated	NULL
expression	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
key	NULL
roles	NULL
in	NULL
cell	NULL
proliferation	NULL
or	NULL
differentiation	NULL
can	NULL
lead	NULL
to	NULL
gain-of-function	NULL
abnormalities	NULL
that	NULL
give	NULL
rise	NULL
to	NULL
diverse	NULL
types	NULL
of	NULL
human	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
(	NULL
34	NULL
,	NULL
35	NULL
,	NULL
49	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
mechanism	NULL
,	NULL
interference	NULL
with	NULL
biochemical	NULL
pathways	NULL
that	NULL
control	NULL
apoptosis	NULL
,	NULL
is	NULL
attracting	NULL
increased	NULL
attention	NULL
because	NULL
of	NULL
recognition	NULL
that	NULL
the	NULL
BCL-2	NULL
oncogene	NULL
in	NULL
human	NULL
B-cell	NULL
lymphoma	NULL
functions	NULL
by	NULL
inhibiting	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
31	NULL
,	NULL
45	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Originally	NULL
identified	NULL
as	NULL
a	NULL
result	NULL
of	NULL
its	NULL
translocation	NULL
into	NULL
the	NULL
immunoglobulin	NULL
(	NULL
/g	NULL
)	NULL
heavy-chain	NULL
locus	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
55	NULL
)	NULL
,	NULL
BCL-2	NULL
encodes	NULL
a	NULL
membrane-associated	NULL
protein	NULL
that	NULL
acts	NULL
as	NULL
a	NULL
dominant	NULL
repressor	NULL
of	NULL
multiple	NULL
independent	NULL
signal	NULL
transduction	NULL
pathways	NULL
culminating	NULL
in	NULL
cell	NULL
death	NULL
(	NULL
53	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
inappropriate	NULL
expression	NULL
of	NULL
BCL-2	NULL
in	NULL
mature	NULL
lymphocytes	NULL
extends	NULL
their	NULL
lon-gevity	NULL
,	NULL
permitting	NULL
the	NULL
accumulation	NULL
of	NULL
transforming	NULL
mutations	NULL
,	NULL
including	NULL
those	NULL
that	NULL
otherwise	NULL
would	NULL
result	NULL
in	NULL
cell	NULL
death	NULL
(	NULL
57	NULL
,	NULL
59	NULL
)	NULL
.	NULL

We	NULL
have	NULL
published	NULL
data	NULL
indicating	NULL
that	NULL
the	NULL
product	NULL
of	NULL
the	NULL
E2A-HLF	NULL
fusion	NULL
gene	NULL
in	NULL
acute	NULL
pro-B-cell	NULL
leukemia	NULL
also	NULL
functions	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Human	NULL
leukemia	NULL
cells	NULL
carrying	NULL
the	NULL
translocation	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
rapidly	NULL
died	NULL
by	NULL
apoptosis	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
332	NULL
N.	NULL
Lau-derdale	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38105	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
901	NULL
)	NULL
495-3514	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
901	NULL
)	NULL
495-2032	NULL
.	NULL

E-mail	NULL
:	NULL
thomas.look	NULL
@	NULL
stfude.org	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Yamanashi	NULL
Medical	NULL
University	NULL
,	NULL
Tamaho	NULL
,	NULL
Yamanashi	NULL
409-38	NULL
,	NULL
Japan	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Kyoto	NULL
Prefectural	NULL
University	NULL
of	NULL
Medicine	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
602	NULL
,	NULL
Japan	NULL
.	NULL

6035	NULL
when	NULL
programmed	NULL
to	NULL
express	NULL
a	NULL
dominant-negative	NULL
suppressor	NULL
of	NULL
the	NULL
chimeric	NULL
EZA-HLF	NULL
protein	NULL
.	NULL

Moreover	NULL
,	NULL
E2A-HLF	NULL
blocks	NULL
apoptosis	NULL
in	NULL
growth	NULL
factor-deprived	NULL
murine	NULL
pro-B	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
chimeric	NULL
protein	NULL
contributes	NULL
to	NULL
leukemic	NULL
transformation	NULL
of	NULL
immature	NULL
lymphoid	NULL
cells	NULL
by	NULL
preventing	NULL
their	NULL
death	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
close	NULL
sequence	NULL
identity	NULL
between	NULL
the	NULL
basic	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
DNA-binding	NULL
and	NULL
protein	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
(	NULL
hepatic	NULL
leukemic	NULL
factor	NULL
)	NULL
and	NULL
that	NULL
of	NULL
CES-2	NULL
(	NULL
39	NULL
)	NULL
,	NULL
a	NULL
cell	NULL
death	NULL
specification	NULL
protein	NULL
in	NULL
the	NULL
nematode	NULL
Caenorhabditis	NULL
elegans	NULL
(	NULL
39	NULL
)	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
E2A-HLF	NULL
blocks	NULL
a	NULL
very	NULL
early	NULL
step	NULL
within	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
apoptotic	NULL
pathway	NULL
in	NULL
pro-B	NULL
lymphocytes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
this	NULL
fusion	NULL
oncoprotein	NULL
in	NULL
the	NULL
genesis	NULL
of	NULL
acute	NULL
leukemia	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
contributions	NULL
of	NULL
its	NULL
various	NULL
structural	NULL
motifs	NULL
to	NULL
the	NULL
antiapoptotic	NULL
effect	NULL
seen	NULL
in	NULL
murine	NULL
pro-B	NULL
cells	NULL
.	NULL

This	NULL
strategy	NULL
seemed	NULL
necessary	NULL
in	NULL
view	NULL
of	NULL
research	NULL
implicating	NULL
EZA	NULL
and	NULL
related	NULL
E	NULL
proteins	NULL
in	NULL
early	NULL
B-cell	NULL
development	NULL
.	NULL

The	NULL
E	NULL
proteins	NULL
form	NULL
a	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
(	NULL
HLH	NULL
)	NULL
proteins	NULL
that	NULL
include	NULL
the	NULL
£24	NULL
gene	NULL
products	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
as	NULL
well	NULL
as	NULL
E2-2	NULL
,	NULL
HEB	NULL
,	NULL
and	NULL
daughterless	NULL
,	NULL
a	NULL
Drosophile	NULL
protein	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
E	NULL
proteins	NULL
have	NULL
a	NULL
wide	NULL
tissue	NULL
distribution	NULL
and	NULL
can	NULL
bind	NULL
to	NULL
DNA	NULL
either	NULL
as	NULL
homodimers	NULL
or	NULL
as	NULL
heterodimers	NULL
with	NULL
other	NULL
types	NULL
of	NULL
lineage-restricted	NULL
bHLH	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
MASH1	NULL
(	NULL
mammalian	NULL
achaete-scute	NULL
homolog	NULL
1	NULL
)	NULL
,	NULL
ADD1	NULL
,	NULL
Scler-axis	NULL
(	NULL
Scl1	NULL
)	NULL
,	NULL
and	NULL
Tall/SCL	NULL
(	NULL
12	NULL
,	NULL
18-20	NULL
,	NULL
51	NULL
,	NULL
54	NULL
,	NULL
58	NULL
)	NULL
.	NULL

They	NULL
also	NULL
can	NULL
interact	NULL
with	NULL
the	NULL
Id	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
lack	NULL
functional	NULL
DNA-binding	NULL
domains	NULL
and	NULL
are	NULL
able	NULL
to	NULL
oppose	NULL
the	NULL
action	NULL
of	NULL
E.	NULL
proteins	NULL
by	NULL
sequestering	NULL
them	NULL
into	NULL
nonfunctional	NULL
complexes	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
relevance	NULL
to	NULL
the	NULL
present	NULL
study	NULL
,	NULL
two	NULL
EZA	NULL
gene	NULL
6036	NULL
INUKAI	NULL
ET	NULL
AL	NULL
.	NULL

products	NULL
,	NULL
E12	NULL
and	NULL
E47	NULL
,	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
normal	NULL
B-cell	NULL
differentiation	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
61	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
neither	NULL
DNA	NULL
binding	NULL
nor	NULL
protein	NULL
dimerization	NULL
through	NULL
the	NULL
bZIP	NULL
domain	NULL
of	NULL
HLF	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
prolongation	NULL
of	NULL
cell	NULL
survival	NULL
after	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

Instead	NULL
,	NULL
apoptosis	NULL
was	NULL
uniformly	NULL
inhibited	NULL
by	NULL
mutant	NULL
proteins	NULL
that	NULL
contained	NULL
either	NULL
or	NULL
both	NULL
of	NULL
the	NULL
E2A	NULL
transactivating	NULL
domains	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
disabled	NULL
HLF	NULL
DNA-binding	NULL
region	NULL
.	NULL

This	NULL
finding	NULL
emphasizes	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
transactivation	NULL
domains	NULL
of	NULL
EZA	NULL
and	NULL
suggests	NULL
that	NULL
protein-protein	NULL
interactions	NULL
mediated	NULL
by	NULL
these	NULL
domains	NULL
allow	NULL
the	NULL
chimeric	NULL
factor	NULL
to	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
apoptotic	NULL
program	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
eukaryotic	NULL
expression	NULL
vectors	NULL
.	NULL

Expression	NULL
plasmids	NULL
containing	NULL
wild-type	NULL
and	NULL
mutated	NULL
£E24-HLF	NULL
,	NULL
E24	NULL
,	NULL
and	NULL
HLF	NULL
cDNAs	NULL
were	NULL
constructed	NULL
with	NULL
the	NULL
pMT-CB6+	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
F.	NULL
Rauscher	NULL
III	NULL
,	NULL
Wistar	NULL
Institute	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pa.	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
inserted	NULL
cDNA	NULL
under	NULL
control	NULL
of	NULL
a	NULL
sheep	NULL
metallothioncin	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
.	NULL

Several	NULL
of	NULL
the	NULL
mutant	NULL
E2A-HLF	NULL
expression	NULL
constructs	NULL
used	NULL
in	NULL
this	NULL
study	NULL
have	NULL
been	NULL
described	NULL
in	NULL
earlier	NULL
publications	NULL
(	NULL
29	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Deletion	NULL
mutants	NULL
of	NULL
E2A-HLF	NULL
were	NULL
prepared	NULL
by	NULL
PCR	NULL
and	NULL
standard	NULL
cloning	NULL
methods	NULL
.	NULL

E2A-HLF	NULL
proteins	NULL
carrying	NULL
amino	NULL
acid	NULL
substitutions	NULL
were	NULL
designated	NULL
by	NULL
the	NULL
relevant	NULL
amino	NULL
acid	NULL
numbers	NULL
,	NULL
with	NULL
single-letter	NULL
codes	NULL
used	NULL
to	NULL
designate	NULL
the	NULL
substitutions	NULL
.	NULL

DNA	NULL
fragments	NULL
generated	NULL
by	NULL
PCR	NULL
were	NULL
sequenced	NULL
to	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
mutations	NULL
had	NULL
been	NULL
introduced	NULL
by	NULL
the	NULL
amplification	NULL
procedure	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
cell	NULL
survival	NULL
assay	NULL
.	NULL

FL5.12	NULL
pro-B	NULL
lymphocytes	NULL
(	NULL
38	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
10	NULL
%	NULL
WEHI-3B-conditioned	NULL
medium	NULL
(	NULL
as	NULL
a	NULL
source	NULL
of	NULL
interleukin-3	NULL
[	NULL
IL-3	NULL
]	NULL
)	NULL
.	NULL

Transfectants	NULL
were	NULL
generated	NULL
by	NULL
electroporation	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
and	NULL
80	NULL
pg	NULL
of	NULL
DNA	NULL
with	NULL
a	NULL
gene	NULL
pulser	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
set	NULL
at	NULL
300	NULL
V	NULL
and	NULL
960	NULL
mF	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
24-well	NULL
dishes	NULL
and	NULL
selected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
neomycin	NULL
analog	NULL
G418	NULL
(	NULL
0.6	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
2	NULL
weeks	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
protein	NULL
expression	NULL
with	NULL
zinc	NULL
in	NULL
G418-resistant	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
,	NULL
and	NULL
three	NULL
to	NULL
six	NULL
independent	NULL
pools	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
expected	NULL
protein	NULL
at	NULL
comparable	NULL
levels	NULL
were	NULL
selected	NULL
for	NULL
further	NULL
experimentation	NULL
.	NULL

For	NULL
cell	NULL
survival	NULL
assays	NULL
,	NULL
protein	NULL
expression	NULL
was	NULL
induced	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
100	NULL
uM	NULL
ZnSQ	NULL
,	NULL
for	NULL
16	NULL
h	NULL
prior	NULL
to	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

IL-3	NULL
was	NULL
removed	NULL
by	NULL
repeated	NULL
centrifugation	NULL
in	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
adjusted	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
per	NULL
ml	NULL
on	NULL
day	NULL
0	NULL
and	NULL
cultured	NULL
without	NULL
IL-3	NULL
.	NULL

Viable	NULL
cell	NULL
counts	NULL
were	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

EMSA	NULL
.	NULL

Binding	NULL
reactions	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
*°P-end-labeled	NULL
DNA	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cpm	NULL
)	NULL
containing	NULL
the	NULL
underlined	NULL
HLF	NULL
consensus	NULL
binding	NULL
site	NULL
sequence	NULL
(	NULL
HLF-CS	NULL
probe	NULL
;	NULL
5'-GCTACATATTACGTAACAAGCGTT-3	NULL
'	NULL
)	NULL
in	NULL
10	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
12	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
4	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
133	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
ug	NULL
of	NULL
sheared	NULL
calf	NULL
thymus	NULL
DNA	NULL
,	NULL
300	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
transfected	NULL
FL5.12	NULL
cells	NULL
by	NULL
standard	NULL
procedures	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A	NULL
1,500-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
M4	NULL
oligo-nucleotide	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
4-bp	NULL
mismatch	NULL
(	NULL
boldfaced	NULL
)	NULL
with	NULL
the	NULL
HLF-CS	NULL
probe	NULL
(	NULL
5'-GCTACATAACACGTGTCAAGCGTT-3	NULL
'	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
containing	NULL
nuclear	NULL
extracts	NULL
from	NULL
FL5.12	NULL
cells	NULL
to	NULL
block	NULL
nonspecific	NULL
binding	NULL
.	NULL

The	NULL
entire	NULL
mixture	NULL
was	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nondenaturing	NULL
polyacryl-amide	NULL
gels	NULL
containing	NULL
4	NULL
%	NULL
acrylamide	NULL
and	NULL
2.5	NULL
%	NULL
glycerol	NULL
were	NULL
prerun	NULL
at	NULL
4°C	NULL
in	NULL
a	NULL
high-ionic-strength	NULL
Tris-glycine	NULL
buffer	NULL
for	NULL
30	NULL
min	NULL
,	NULL
loaded	NULL
with	NULL
the	NULL
samples	NULL
containing	NULL
protein-DNA	NULL
complexes	NULL
,	NULL
run	NULL
at	NULL
35	NULL
mA	NULL
for	NULL
approximately	NULL
90	NULL
min	NULL
,	NULL
dried	NULL
under	NULL
a	NULL
vacuum	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
solubilized	NULL
in	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1.0	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
)	NULL
,	NULL
and	NULL
total	NULL
cellular	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

After	NULL
wet	NULL
electrotransfer	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
anti-E2A	NULL
or	NULL
anti-HLF	NULL
(	NULL
C	NULL
)	NULL
rabbit	NULL
serum	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
primary	NULL
antibody	NULL
followed	NULL
by	NULL
horseradish	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
secondary	NULL
antibodies	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
Life	NULL
Science	NULL
,	NULL
Inc.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
TL	NULL
.	NULL
)	NULL

.	NULL

Immunofluorescence	NULL
studies	NULL
.	NULL

FL5.12	NULL
cells	NULL
expressing	NULL
cach	NULL
construct	NULL
were	NULL
cultured	NULL
with	NULL
100	NULL
wM	NULL
ZnSO	NULL
,	NULL
for	NULL
16	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
growth	NULL
factor	NULL
and	NULL
then	NULL
fixed	NULL
with	NULL
3.7	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
treated	NULL
with	NULL
acetone	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
IgG-purified	NULL
anti-E2A	NULL
(	NULL
1:500	NULL
dilution	NULL
)	NULL
or	NULL
HLF	NULL
(	NULL
C	NULL
)	NULL
(	NULL
1:3,000	NULL
dilution	NULL
)	NULL
rabbit	NULL
serum	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothiocyanate-conju-gated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
.	NULL

Cell	NULL
nuclei	NULL
were	NULL
counterstained	NULL
with	NULL
DAPI	NULL
(	NULL
4',6-diamidino-2-phenylindole	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

a	NULL
vector	NULL
.	NULL

#	NULL
104	NULL
#	NULL
112	NULL
#	NULL
116	NULL
#	NULL
120	NULL
#	NULL
122	NULL
ri	NULL
emm	NULL
r-1	NULL
roa	NULL
r	NULL
--	NULL
ra	NULL
Zn	NULL
-	NULL
+	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
c-	NULL
4+	NULL
-	NULL
4+	NULL
-	NULL
+	NULL
(	NULL
kDa	NULL
)	NULL
«	NULL
ap	NULL
--	NULL
GB	NULL
-que	NULL
--	NULL
amp	NULL
--	NULL
a	NULL
-	NULL
66	NULL
\	NULL
-46	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Number	NULL
of	NULL
living	NULL
cells	NULL
(	NULL
10°	NULL
per	NULL
mi	NULL
)	NULL
5	NULL
10	NULL
15	NULL
oem	NULL
s	NULL
[	NULL
ewer	NULL
~+-+	NULL
+	NULL
+	NULL
+0	NULL
+	NULL
Zn	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
E2A-HLF	NULL
protein	NULL
expression	NULL
in	NULL
FL5.12	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
HLF	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
of	NULL
five	NULL
independent	NULL
E2A-HLF-posi-tive	NULL
,	NULL
G418-resistant	NULL
transfected	NULL
pools	NULL
of	NULL
FL5.12	NULL
cells	NULL
and	NULL
an	NULL
empty	NULL
vector-transfected	NULL
cell	NULL
pool	NULL
,	NULL
all	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
of	NULL
100	NULL
aM	NULL
ZnSQ	NULL
,	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Growth	NULL
of	NULL
FL5.12	NULL
cells	NULL
induced	NULL
to	NULL
express	NULL
the	NULL
E2A-HLF	NULL
protein	NULL
,	NULL
together	NULL
with	NULL
growth	NULL
of	NULL
control	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
empty	NULL
vector	NULL
.	NULL

Cells	NULL
growing	NULL
exponentially	NULL
in	NULL
IL-3-supple-mented	NULL
medium	NULL
for	NULL
16	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
zinc	NULL
were	NULL
adjusted	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
on	NULL
day	NULL
0	NULL
and	NULL
cultured	NULL
without	NULL
IL-3	NULL
for	NULL
15	NULL
days	NULL
.	NULL

The	NULL
growth	NULL
factor	NULL
was	NULL
reintroduced	NULL
to	NULL
the	NULL
cultures	NULL
on	NULL
day	NULL
15	NULL
(	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
shaded	NULL
region	NULL
indicates	NULL
the	NULL
ranges	NULL
of	NULL
cell	NULL
counts	NULL
for	NULL
E2A-HLF-transfected	NULL
pools	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
zinc	NULL
and	NULL
control	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
metal	NULL
.	NULL

Each	NULL
symbol	NULL
represents	NULL
a	NULL
discrete	NULL
pool	NULL
of	NULL
E2A-HLF-transfected	NULL
,	NULL
G418-resistant	NULL
cells	NULL
;	NULL
open	NULL
circles	NULL
,	NULL
pool	NULL
104	NULL
;	NULL
open	NULL
triangles	NULL
,	NULL
pool	NULL
112	NULL
;	NULL
open	NULL
squares	NULL
,	NULL
pool	NULL
116	NULL
;	NULL
closed	NULL
circles	NULL
,	NULL
pool	NULL
120	NULL
;	NULL
and	NULL
open	NULL
diamonds	NULL
,	NULL
pool	NULL
122	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
a	NULL
representative	NULL
pool	NULL
of	NULL
transfected	NULL
cells	NULL
(	NULL
pool	NULL
116	NULL
;	NULL
open	NULL
squares	NULL
in	NULL
panel	NULL
B	NULL
)	NULL
expressing	NULL
E2A-HLF	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
zinc	NULL
,	NULL
as	NULL
determined	NULL
from	NULL
DNA	NULL
histograms	NULL
obtained	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

19	NULL
(	NULL
days	NULL
)	NULL
50	NULL
Loot	NULL
N	NULL
N	NULL
N	NULL
N	NULL
N	NULL
N	NULL
N	NULL
§	NULL
N	NULL
N	NULL
B	NULL
Cell-cycle	NULL
distribution	NULL
(	NULL
%	NULL
)	NULL
0	NULL
RESULTS	NULL
E2A-HLF	NULL
prolongs	NULL
the	NULL
survival	NULL
of	NULL
IL-3-dependent	NULL
murine	NULL
pro-B	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
growth	NULL
factor	NULL
.	NULL

We	NULL
conditionally	NULL
expressed	NULL
the	NULL
EZA-HLF	NULL
protein	NULL
by	NULL
using	NULL
a	NULL
zinc-regulated	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
(	NULL
pMT-CB6+	NULL
)	NULL
in	NULL
FLS5.12	NULL
cells	NULL
,	NULL
an	NULL
IL-3-dependent	NULL
line	NULL
of	NULL
murine	NULL
pro-B	NULL
lymphocytes	NULL
.	NULL

Each	NULL
independent	NULL
pool	NULL
of	NULL
cells	NULL
isolated	NULL
after	NULL
G418	NULL
selection	NULL
expressed	NULL
E2A-HLF	NULL
proteins	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
uM	NULL
ZnSO	NULL
,	NULL
at	NULL
levels	NULL
that	NULL
were	NULL
approximately	NULL
20-	NULL
to	NULL
30-fold	NULL
higher	NULL
than	NULL
background	NULL
levels	NULL
in	NULL
medium	NULL
lacking	NULL
the	NULL
metal	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

When	NULL
IL-3	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
medium	NULL
,	NULL
cells	NULL
from	NULL
the	NULL
EZ2A-HLF-express-ing	NULL
pools	NULL
survived	NULL
for	NULL
longer	NULL
than	NULL
2	NULL
weeks	NULL
when	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
,	NULL
whereas	NULL
in	NULL
medium	NULL
lacking	NULL
the	NULL
metal	NULL
,	NULL
they	NULL
rapidly	NULL
underwent	NULL
apoptosis	NULL
,	NULL
as	NULL
did	NULL
control	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
empty	NULL
vector	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
zinc	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
.	NULL

%	NULL
‘	NULL
low	NULL
cytometric	NULL
analysis	NULL
showed	NULL
an	NULL
accumulation	NULL
of	NULL
E2A-HLF-positive	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
/G	NULL
,	NULL
phase	NULL
after	NULL
IL-3	NULL
withdrawal	NULL
(	NULL
Fig	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
Empty	NULL
vector	NULL
E2A-HLF	NULL
Empty	NULL
vector	NULL
E2A-HLF	NULL
E2A	NULL
(	NULL
E47	NULL
)	NULL
Fn	NULL
=	NULL
to	NULL
-	NULL
t+	NULL
-	NULL
to	NULL
<	NULL
-	NULL
to-	NULL
t	NULL
-	NULL
&	NULL
+	NULL
-o	NULL
oo+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
C	NULL
0	NULL
>	NULL
>	NULL
l	NULL
m	NULL
t	NULL
9	NULL
``	NULL
-s	NULL
ANTIAPOPTOTIC	NULL
ROLE	NULL
OF	NULL
E2A-HLF	NULL
IN	NULL
pro-B	NULL
CELLS	NULL
(	NULL
kDa	NULL
)	NULL
-46	NULL
6037	NULL
B~§	NULL
8	NULL
&	NULL
>	NULL
EEE	NULL
2	NULL
4	NULL
z	NULL
x	NULL
Eﬁﬁﬁb	NULL
LJ	NULL
Wo	NULL
Wo	NULL
I	NULL
~~B	NULL
1	NULL
2	NULL
3	NULL
405	NULL
Number	NULL
of	NULL
living	NULL
cells	NULL
4	NULL
days	NULL
after	NULL
IL-3	NULL
deprivation	NULL
(	NULL
10°/m1	NULL
)	NULL
15	NULL
Fusion	NULL
site	NULL
Zn	NULL
I	NULL
I	NULL
I	NULL
E2A-HLF	NULL
I	NULL
~	NULL
+V	NULL
--	NULL
Joining	NULL
region	NULL
v	NULL
E	NULL
:	NULL
Tk	NULL
TAD	NULL
|bzip	NULL
PAR	NULL
HLF	NULL
=-=re-	NULL
m	NULL
N	NULL
p	NULL
m	NULL
B	NULL
fe	NULL
&	NULL
Go	NULL
CXX	NULL
>	NULL
I	NULL
___	NULL
]	NULL
I	NULL
I	NULL
+	NULL
AD2	NULL
bHLH	NULL
Aoi	NULL
|	NULL
NLS	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Antiapoptotic	NULL
activity	NULL
of	NULL
wild-type	NULL
E2A	NULL
(	NULL
E12	NULL
and	NULL
E47	NULL
)	NULL
and	NULL
HLF	NULL
proteins	NULL
in	NULL
FL5.12	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
HLF	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
or	NULL
E2A	NULL
antiserum	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
14	NULL
)	NULL
of	NULL
proteins	NULL
in	NULL
transfected	NULL
FL5.12	NULL
pools	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
HLF-CS	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
transfected	NULL
FL5.12	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
antiapoptotic	NULL
activities	NULL
of	NULL
normal	NULL
E2A	NULL
and	NULL
HLF	NULL
proteins	NULL
with	NULL
that	NULL
of	NULL
the	NULL
E2A-HLF	NULL
protein	NULL
.	NULL

The	NULL
numbers	NULL
of	NULL
living	NULL
cells	NULL
in	NULL
pools	NULL
expressing	NULL
the	NULL
designated	NULL
protein	NULL
are	NULL
represented	NULL
by	NULL
bars	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
upper	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lower	NULL
)	NULL
of	NULL
zinc	NULL
after	NULL
4	NULL
days	NULL
of	NULL
culture	NULL
without	NULL
IL-3	NULL
.	NULL

The	NULL
values	NULL
are	NULL
the	NULL
means	NULL
of	NULL
results	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independently	NULL
analyzed	NULL
transfected	NULL
cell	NULL
pools	NULL
;	NULL
standard	NULL
deviations	NULL
are	NULL
given	NULL
at	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
bars	NULL
.	NULL

TAD	NULL
,	NULL
transactivation	NULL
domain	NULL
;	NULL
PAR	NULL
,	NULL
proline	NULL
and	NULL
acidic	NULL
amino	NULL
acid-rich	NULL
region	NULL
;	NULL
NLS	NULL
,	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

1c	NULL
)	NULL
.	NULL

This	NULL
response	NULL
to	NULL
growth	NULL
factor	NULL
depletion	NULL
persisted	NULL
for	NULL
2	NULL
weeks	NULL
of	NULL
culture	NULL
;	NULL
however	NULL
,	NULL
with	NULL
restoration	NULL
of	NULL
IL-3	NULL
,	NULL
the	NULL
EZ2A-HLF-expressing	NULL
cells	NULL
reentered	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
resumed	NULL
growth	NULL
.	NULL

Thus	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
observations	NULL
of	NULL
Baf-3	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
,	NULL
E2A-HLF	NULL
protects	NULL
FL5.12	NULL
cells	NULL
from	NULL
the	NULL
apoptotic	NULL
effect	NULL
of	NULL
IL-3	NULL
withdrawal	NULL
but	NULL
does	NULL
not	NULL
replace	NULL
the	NULL
cell	NULL
cycle-stimulatory	NULL
effects	NULL
of	NULL
the	NULL
growth	NULL
factor	NULL
.	NULL

Wild-type	NULL
E2A	NULL
(	NULL
E12	NULL
and	NULL
E47	NULL
)	NULL
and	NULL
HLF	NULL
proteins	NULL
do	NULL
not	NULL
promote	NULL
survival	NULL
after	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

HLF	NULL
is	NULL
normally	NULL
expressed	NULL
in	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
brain	NULL
but	NULL
not	NULL
in	NULL
B-lym-phoid	NULL
cells	NULL
,	NULL
whereas	NULL
EZA	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
pro-B	NULL
lymphoblasts	NULL
(	NULL
24	NULL
,	NULL
27	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
wild-type	NULL
E2A	NULL
or	NULL
HLF	NULL
possesses	NULL
intrinsic	NULL
antiapoptotic	NULL
properties	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
translocation-induced	NULL
recombination	NULL
in	NULL
pro-B	NULL
lymphocytes	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
enforced	NULL
expression	NULL
of	NULL
HLF	NULL
and	NULL
two	NULL
different	NULL
splice	NULL
forms	NULL
of	NULL
EZA	NULL
(	NULL
E12	NULL
and	NULL
E47	NULL
)	NULL
(	NULL
42	NULL
)	NULL
on	NULL
the	NULL
survival	NULL
of	NULL
FL5.12	NULL
cells	NULL
.	NULL

Human	NULL
£72	NULL
,	NULL
£47	NULL
,	NULL
and	NULL
HLF	NULL
cDNAs	NULL
were	NULL
introduced	NULL
separately	NULL
into	NULL
the	NULL
cells	NULL
under	NULL
control	NULL
of	NULL
the	NULL
zinc-regulated	NULL
metallothionein	NULL
promoter	NULL
.	NULL

Immu-noblots	NULL
of	NULL
lysates	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
confirmed	NULL
regulated	NULL
expression	NULL
of	NULL
the	NULL
desired	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

EMSA	NULL
with	NULL
an	NULL
HLF	NULL
consensus	NULL
sequence	NULL
(	NULL
HLF-CS	NULL
)	NULL
oligonucleotide	NULL
probe	NULL
detected	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
FL5.12	NULL
cells	NULL
expressing	NULL
either	NULL
HLF	NULL
or	NULL
E2A-HLF	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

After	NULL
IL-3	NULL
withdrawal	NULL
,	NULL
neither	NULL
intact	NULL
E2A	NULL
nor	NULL
HLF	NULL
proteins	NULL
prolonged	NULL
cell	NULL
survival	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
despite	NULL
expression	NULL
of	NULL
these	NULL
proteins	NULL
at	NULL
levels	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
the	NULL
E2A-HLF	NULL
fusion	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
efficient	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
that	NULL
both	NULL
proteins	NULL
be	NULL
removed	NULL
from	NULL
their	NULL
normal	NULL
context	NULL
and	NULL
critical	NULL
segments	NULL
of	NULL
each	NULL
be	NULL
linked	NULL
to	NULL
form	NULL
a	NULL
functional	NULL
chimeric	NULL
molecule	NULL
.	NULL

Antiapoptotic	NULL
activity	NULL
of	NULL
non-	NULL
DNA-binding	NULL
mutants	NULL
of	NULL
E2A-HLF	NULL
.	NULL

We	NULL
constructed	NULL
a	NULL
set	NULL
of	NULL
EZA-HLF	NULL
mutants	NULL
to	NULL
test	NULL
the	NULL
requirement	NULL
for	NULL
DNA	NULL
binding	NULL
in	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
fusion	NULL
protein	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
a	NULL
basic	NULL
region	NULL
mutant	NULL
(	NULL
BX	NULL
)	NULL
,	NULL
containing	NULL
substitutions	NULL
of	NULL
six	NULL
critical	NULL
basic	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
DNA-binding	NULL
portion	NULL
of	NULL
the	NULL
HLF	NULL
bZIP	NULL
domain	NULL
.	NULL

Even	NULL
though	NULL
the	NULL
mutant	NULL
's	NULL
level	NULL
of	NULL
expression	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
intact	NULL
E2A-HLF	NULL
in	NULL
FL5.12	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
it	NULL
did	NULL
not	NULL
form	NULL
complexes	NULL
with	NULL
DNA	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
EMSA	NULL
with	NULL
the	NULL
HLF-CS	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
expected	NULL
loss	NULL
of	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Surprisingly	NULL
,	NULL
this	NULL
mutant	NULL
efficiently	NULL
promoted	NULL
cell	NULL
survival	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-3	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
antiapoptotic	NULL
property	NULL
of	NULL
EZA-HLF	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
interaction	NULL
with	NULL
DNA	NULL
through	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
HLF	NULL
.	NULL

Results	NULL
with	NULL
two	NULL
additional	NULL
mutants	NULL
containing	NULL
deletions	NULL
in	NULL
the	NULL
HLF	NULL
basic	NULL
region	NULL
(	NULL
A509-515	NULL
and	NULL
A509-518	NULL
[	NULL
Fig	NULL
.	NULL

3C	NULL
]	NULL
)	NULL
supported	NULL
this	NULL
interpretation	NULL
.	NULL

Despite	NULL
their	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
zinc-treated	NULL
FLS.12	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
neither	NULL
protein	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
HLF-CS	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
yet	NULL
each	NULL
efficiently	NULL
protected	NULL
cells	NULL
from	NULL
apoptotic	NULL
death	NULL
induced	NULL
by	NULL
IL-3	NULL
deprivation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
HLF/BX	NULL
mutant	NULL
,	NULL
which	NULL
carried	NULL
the	NULL
same	NULL
basic	NULL
region	NULL
substi-	NULL
6038	NULL
INUKAI	NULL
ET	NULL
AL	NULL
.	NULL

&	NULL
B	NULL
5	NULL
20	NULL
2	NULL
Ob	NULL
E	NULL
2	NULL
§	NULL
§	NULL
©	NULL
-	NULL
9	NULL
-	NULL
»	NULL
P	NULL
ty	NULL
O	NULL
fe	NULL
co	NULL
<	NULL
<	NULL
C	NULL
LL	NULL
o	NULL
o	NULL
o	NULL
co	NULL
O	NULL
-	NULL
i	NULL
i	NULL
)	NULL
<	NULL
L	NULL
I	NULL
4	NULL
4	NULL
4	NULL
<	NULL
4	NULL
I	NULL
U	NULL
I	NULL
if	NULL
U	NULL
W	NULL
1	NULL
Zn	NULL
=	NULL
+0	NULL
<	NULL
-	NULL
+0	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
&	NULL
+	NULL
(	NULL
kDa	NULL
)	NULL
ose	NULL
seracs	NULL
Basins	NULL
'	NULL
u	NULL
P	NULL
J	NULL
we	NULL
Gueep	NULL
-	NULL
«	NULL
***	NULL
__	NULL
GG	NULL
Nl	NULL
t	NULL
..-	NULL
.	NULL

dP	NULL
wal	NULL
-*	NULL
_46	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
C	NULL
E2A	NULL
HLF	NULL
Joining	NULL
Basic	NULL
Zipper	NULL
AD1	NULL
AD2	NULL
region	NULL
region	NULL
region	NULL
+	NULL
4	NULL
C	NULL
¥	NULL
E2A-HLF	NULL
||	NULL
E2A-HLF	NULL
I	NULL
BX	NULL
A509-515	NULL
NI	NULL
I	NULL
LL	NULL
LC	NULL
A509-518	NULL
W	NULL
A508-551	NULL
N	NULL
]	NULL
§§§	NULL
AMA84-574	NULL
NI	NULL
HLF	NULL
/	NULL
BX	NULL
Jp	NULL
I	NULL
LLL	NULL
C	NULL
§P-SY-PP	NULL
Empty	NULL
vector	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

X	NULL
[	NULL
+a	NULL
]	NULL
LC	NULL
wo	NULL
0	NULL
ost	NULL
wo	NULL
45	NULL
as	NULL
D	NULL
3	NULL
©	NULL
§	NULL
5	NULL
5	NULL
8	NULL
5	NULL
I	NULL
-t	NULL
8	NULL
d	NULL
o	NULL
6	NULL
<	NULL
§	NULL
<	NULL
LLooooo	NULL
~	NULL
IJ	NULL
©	NULL
in	NULL
©	NULL
<	NULL
1	NULL
w	NULL
I	NULL
4	NULL
4	NULL
4	NULL
4	NULL
sons	NULL
|	NULL
©9W	NULL
cues	NULL
|	NULL
wh	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
Number	NULL
of	NULL
living	NULL
cells	NULL
4	NULL
days	NULL
after	NULL
IL-3	NULL
deprivation	NULL
(	NULL
10°	NULL
/m1	NULL
)	NULL
15	NULL
WI	NULL
?	NULL

I	NULL
MA	NULL
--	NULL
A	NULL
IV-	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Antiapoptotic	NULL
activities	NULL
of	NULL
E2A-HLF	NULL
and	NULL
HLF	NULL
proteins	NULL
with	NULL
deletions	NULL
or	NULL
amino	NULL
acid	NULL
substitutions	NULL
in	NULL
the	NULL
bZIP	NULL
domain	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
HLF	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
or	NULL
E2A	NULL
antiserum	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
12	NULL
)	NULL
of	NULL
proteins	NULL
in	NULL
transfected	NULL
FL5.12	NULL
pools	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
HLF-CS	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
transfected	NULL
FL5.12	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
the	NULL
protein	NULL
expressed	NULL
from	NULL
each	NULL
construct	NULL
with	NULL
that	NULL
of	NULL
the	NULL
E2A-HLF	NULL
protein	NULL
.	NULL

Diagrams	NULL
of	NULL
the	NULL
E2A-HLF	NULL
mutant	NULL
proteins	NULL
analyzed	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Bars	NULL
indicate	NULL
the	NULL
numbers	NULL
of	NULL
living	NULL
cells	NULL
in	NULL
each	NULL
pool	NULL
that	NULL
expressed	NULL
the	NULL
designated	NULL
proteins	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
upper	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lower	NULL
)	NULL
of	NULL
zinc	NULL
after	NULL
4	NULL
days	NULL
of	NULL
culture	NULL
without	NULL
IL-3	NULL
.	NULL

The	NULL
values	NULL
are	NULL
the	NULL
means	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
pools	NULL
;	NULL
standard	NULL
deviations	NULL
are	NULL
given	NULL
at	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
bars	NULL
.	NULL

Notation	NULL
is	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

tutions	NULL
as	NULL
E2A-HLF/BX	NULL
but	NULL
lacked	NULL
the	NULL
entire	NULL
E2A	NULL
segment	NULL
,	NULL
did	NULL
not	NULL
extend	NULL
cell	NULL
survival	NULL
after	NULL
IL-3-deprivation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
underscoring	NULL
the	NULL
major	NULL
antiapoptotic	NULL
role	NULL
of	NULL
the	NULL
E2A	NULL
portion	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
.	NULL

We	NULL
also	NULL
considered	NULL
that	NULL
protein-protein	NULL
dimerization	NULL
through	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
might	NULL
be	NULL
required	NULL
to	NULL
block	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
mutant	NULL
that	NULL
lacked	NULL
both	NULL
the	NULL
DNA-binding	NULL
domain	NULL
and	NULL
most	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
.	NULL

This	NULL
construct	NULL
(	NULL
A508-551	NULL
[	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
;	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
7	NULL
]	NULL
)	NULL
also	NULL
prevented	NULL
the	NULL
apoptotic	NULL
death	NULL
of	NULL
FL5.12	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
interaction	NULL
with	NULL
other	NULL
proteins	NULL
through	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
is	NULL
dispensable	NULL
for	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
fusion	NULL
protein	NULL
.	NULL

Since	NULL
neither	NULL
the	NULL
basic	NULL
region	NULL
nor	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
contributed	NULL
by	NULL
HLF	NULL
appears	NULL
necessary	NULL
for	NULL
the	NULL
antiapoptotic	NULL
function	NULL
of	NULL
EZA-HLF	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
the	NULL
amino-terminal	NULL
segment	NULL
of	NULL
EZ2A	NULL
included	NULL
in	NULL
the	NULL
intact	NULL
fusion	NULL
protein	NULL
might	NULL
be	NULL
sufficient	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
.	NULL

The	NULL
resulting	NULL
construct	NULL
(	NULL
A484-574	NULL
)	NULL
,	NULL
although	NULL
expressed	NULL
more	NULL
weakly	NULL
than	NULL
the	NULL
other	NULL
mutants	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
but	NULL
at	NULL
levels	NULL
approximating	NULL
those	NULL
of	NULL
endoge-nous	NULL
EZA	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
did	NULL
in	NULL
fact	NULL
possess	NULL
antiapoptotic	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Since	NULL
neither	NULL
form	NULL
of	NULL
the	NULL
normal	NULL
E2A	NULL
protein	NULL
(	NULL
E12	NULL
or	NULL
E47	NULL
)	NULL
blocked	NULL
apoptosis	NULL
in	NULL
FL5.12	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
the	NULL
EZA	NULL
amino-terminal	NULL
region	NULL
is	NULL
manifest	NULL
only	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
intact	NULL
bHLH	NULL
domain	NULL
,	NULL
which	NULL
normally	NULL
would	NULL
target	NULL
the	NULL
protein	NULL
to	NULL
E-box	NULL
DNA	NULL
sequence	NULL
motifs	NULL
and	NULL
mediate	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
ANTIAPOPTOTIC	NULL
ROLE	NULL
OF	NULL
E2A-HLF	NULL
IN	NULL
pro-B	NULL
CELLS	NULL
-	NULL
6039	NULL
x	NULL
x	NULL
B	NULL
x	NULL
a	NULL
a	NULL
A	NULL
BJ	NULL
a	NULL
&	NULL
w	NULL
§	NULL
c	NULL
d	NULL
bx	NULL
f	NULL
:	NULL
a	NULL
|f	NULL
x	NULL
%	NULL
%	NULL
%	NULL
o	NULL
fo	NULL
fo	NULL
C	NULL
C3	NULL
CY	NULL
}	NULL
3	NULL
3	NULL
fra	NULL
x	NULL
C	NULL
52	NULL
o	NULL
5	NULL
e	NULL
Lo	NULL
Lo	NULL
uo	NULL
sos	NULL
8	NULL
8	NULL
g	NULL
S	NULL
og	NULL
f	NULL
Og	NULL
g	NULL
{	NULL
0	NULL
§	NULL
s	NULL
sf	NULL
§f	NULL
wou	NULL
ad	NULL
a	NULL
a	NULL
x	NULL
x	NULL
al	NULL
al	NULL
#	NULL
hi	NULL
a	NULL
a	NULL
&	NULL
€	NULL
00	NULL
So	NULL
3	NULL
3	NULL
8	NULL
C	NULL
S	NULL
C	NULL
R	NULL
A	NULL
t	NULL
i	NULL
&	NULL
&	NULL
¢	NULL
T	NULL
5	NULL
&	NULL
z	NULL
x	NULL
S8	NULL
S	NULL
a	NULL
a	NULL
e	NULL
M	NULL
&	NULL
&	NULL
2	NULL
)	NULL
|	NULL
brs	NULL
brs	NULL
Ra	NULL
MZ	NULL
d	NULL
18	NULL
38	NULL
o	NULL
¢	NULL
¢	NULL
|||	NULL
s	NULL
5	NULL
\	NULL
&	NULL
``	NULL
\z\	NULL
2	NULL
)	NULL
'	NULL
%	NULL
I4	NULL
9a	NULL
-	NULL
4	NULL
3	NULL
3	NULL
ei	NULL
a	NULL
f	NULL
|F2	NULL
FZ	NULL
x5	NULL
om	NULL
co	NULL
gc	NULL
-	NULL
&	NULL
%	NULL
a	NULL
a	NULL
r	NULL
ir	NULL
ir	NULL
ir	NULL
ir	NULL
J	NULL
ir	NULL
ir-	NULL
r	NULL
ir	NULL
ir	NULL
y	NULL
ir	NULL
1	NULL
x	NULL
«	NULL
'	NULL
«	NULL
a	NULL
8	NULL
a	NULL
8	NULL
&	NULL
a	NULL
)	NULL
a	NULL
||	NULL
a	NULL
&	NULL
&	NULL
Zn	NULL
-	NULL
4	NULL
o-	NULL
%	NULL
s	NULL
#	NULL
4	NULL
e	NULL
$	NULL
oe	NULL
$	NULL
om	NULL
#	NULL
$	NULL
om	NULL
$	NULL
oke	NULL
$	NULL
e	NULL
$	NULL
ok	NULL
+	NULL
om	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
(	NULL
kDa	NULL
)	NULL
Ngglggzggﬁgaggg	NULL
f	NULL
1	NULL
3	NULL
2	NULL
G	NULL
an	NULL
_	NULL
b	NULL
ao	NULL
=o	NULL
5	NULL
b	NULL
b	NULL
J	NULL
a	NULL
g	NULL
a	NULL
2	NULL
§	NULL
R	NULL
B	NULL
t	NULL
I	NULL
«	NULL
e	NULL
we	NULL
==	NULL
-66	NULL
4	NULL
4	NULL
3	NULL
Y	NULL
$	NULL
2	NULL
2	NULL
2	NULL
@	NULL
%	NULL
3	NULL
9	NULL
§	NULL
§	NULL
§	NULL
_-	NULL
-	NULL
&	NULL
~	NULL
@	NULL
-	NULL
a	NULL
-a	NULL
CS	NULL
fan	NULL
«	NULL
-46	NULL
«	NULL
s	NULL
«	NULL
_	NULL
=	NULL
=	NULL
``	NULL
ore	NULL
1	NULL
Ter	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
.	NULL

.	NULL

luk	NULL
we	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
c	NULL
Intact	NULL
HLF	NULL
DNA-binding	NULL
domain	NULL
Disabled	NULL
HLF	NULL
DNA-binding	NULL
domain	NULL
Number	NULL
of	NULL
living	NULL
cells	NULL
4	NULL
days	NULL
after	NULL
IL-3	NULL
deprivation	NULL
.	NULL

Number	NULL
of	NULL
living	NULL
cells	NULL
4	NULL
days	NULL
after	NULL
IL-3	NULL
deprivation	NULL
Fusion	NULL
site	NULL
.	NULL

,	NULL
(	NULL
10°/mi	NULL
)	NULL
Io	NULL
(	NULL
10°	NULL
imi	NULL
)	NULL
M	NULL
Api	NULL
Ab2	NULL
|	NULL
Zn	NULL
E2AHLE	NULL
at-r42	NULL
f	NULL
we	NULL
w	NULL
;	NULL
l	NULL
+/	NULL
so3v-E,404L-R	NULL
+	NULL
we	NULL
we	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Antiapoptotic	NULL
activities	NULL
mutations	NULL
in	NULL
E2A	NULL
and	NULL
E2A-HLF	NULL
proteins	NULL
with	NULL
intact	NULL
or	NULL
disabled	NULL
(	NULL
BX	NULL
)	NULL
HLF	NULL
DNA-binding	NULL
domains	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
with	NULL
an	NULL
HLF	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
of	NULL
proteins	NULL
in	NULL
transfected	NULL
FL5.12	NULL
cell	NULL
pools	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
HLF-CS	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
transfected	NULL
FL5.12	NULL
clones	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
antiapoptotic	NULL
activities	NULL
of	NULL
EZA-HLF	NULL
proteins	NULL
with	NULL
mutations	NULL
in	NULL
E2A	NULL
and	NULL
intact	NULL
(	NULL
left	NULL
)	NULL
or	NULL
disabled	NULL
(	NULL
right	NULL
)	NULL
HLF	NULL
DNA-binding	NULL
domains	NULL
.	NULL

Diagrams	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Bars	NULL
indicate	NULL
the	NULL
numbers	NULL
of	NULL
living	NULL
cells	NULL
in	NULL
each	NULL
pool	NULL
of	NULL
transfected	NULL
cells	NULL
that	NULL
expressed	NULL
the	NULL
designated	NULL
proteins	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
upper	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lower	NULL
)	NULL
of	NULL
zinc	NULL
after	NULL
4	NULL
days	NULL
of	NULL
culture	NULL
without	NULL
IL-3	NULL
.	NULL

The	NULL
values	NULL
are	NULL
means	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
pools	NULL
;	NULL
standard	NULL
deviations	NULL
are	NULL
given	NULL
at	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
bars	NULL
.	NULL

the	NULL
formation	NULL
of	NULL
homodimeric	NULL
complexes	NULL
and	NULL
heterodimeric	NULL
interactions	NULL
with	NULL
other	NULL
bHLH	NULL
partner	NULL
proteins	NULL
(	NULL
8	NULL
,	NULL
33	NULL
,	NULL
43	NULL
,	NULL
50	NULL
)	NULL
.	NULL

E2A	NULL
structural	NULL
requirements	NULL
for	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
an	NULL
intact	NULL
HLF	NULL
bZIP	NULL
domain	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
portion	NULL
of	NULL
the	NULL
E2A	NULL
amino-terminal	NULL
region	NULL
that	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
antiapoptotic	NULL
effects	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
series	NULL
of	NULL
mutants	NULL
with	NULL
deletions	NULL
or	NULL
substitutions	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
EZA	NULL
functional	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
including	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
transactivation	NULL
domains	NULL
and	NULL
adjacent	NULL
EZA	NULL
sequences	NULL
.	NULL

The	NULL
resulting	NULL
constructs	NULL
were	NULL
fused	NULL
either	NULL
with	NULL
an	NULL
intact	NULL
HLF	NULL
bZIP	NULL
domain	NULL
or	NULL
with	NULL
one	NULL
in	NULL
which	NULL
multiple	NULL
amino	NULL
acid	NULL
substitutions	NULL
were	NULL
introduced	NULL
within	NULL
the	NULL
basic	NULL
region	NULL
to	NULL
prevent	NULL
specific	NULL
DNA	NULL
binding	NULL
.	NULL

When	NULL
expressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
each	NULL
mutant	NULL
protein	NULL
's	NULL
DNA-binding	NULL
properties	NULL
by	NULL
EMSA	NULL
analysis	NULL
depended	NULL
on	NULL
whether	NULL
the	NULL
HLF	NULL
bZIP	NULL
domain	NULL
was	NULL
intact	NULL
or	NULL
contained	NULL
basic	NULL
region	NULL
mutations	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

A	NULL
clear	NULL
pattern	NULL
of	NULL
FL5.12	NULL
cell	NULL
survival	NULL
was	NULL
observed	NULL
for	NULL
cells	NULL
that	NULL
expressed	NULL
fusion	NULL
proteins	NULL
with	NULL
disabled	NULL
HLF	NULL
DNA-binding	NULL
domains	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
in	NULL
that	NULL
virtually	NULL
all	NULL
of	NULL
these	NULL
transfectants	NULL
were	NULL
rescued	NULL
from	NULL
apoptosis	NULL
after	NULL
IL-3	NULL
deprivation	NULL
,	NULL
whether	NULL
functional	NULL
activity	NULL
was	NULL
retained	NULL
by	NULL
the	NULL
AD1	NULL
or	NULL
AD2	NULL
domain	NULL
of	NULL
E2A	NULL
and	NULL
whether	NULL
inactivation	NULL
of	NULL
these	NULL
regions	NULL
was	NULL
achieved	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
entire	NULL
sequence	NULL
or	NULL
by	NULL
point	NULL
mutation	NULL
of	NULL
specific	NULL
amino	NULL
acids	NULL
known	NULL
to	NULL
have	NULL
critical	NULL
functional	NULL
roles	NULL
(	NULL
37	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Only	NULL
two	NULL
of	NULL
the	NULL
non-DNA-binding	NULL
mutants	NULL
failed	NULL
to	NULL
promote	NULL
survival	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

One	NULL
(	NULL
A1-142,277-412	NULL
)	NULL
lacked	NULL
both	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
regions	NULL
,	NULL
while	NULL
the	NULL
other	NULL
(	NULL
19L-R,22F-R/403V-R,404L-R	NULL
)	NULL
incorporated	NULL
point	NULL
mutations	NULL
that	NULL
inactivate	NULL
the	NULL
transactivating	NULL
potential	NULL
of	NULL
both	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
in	NULL
a	NULL
single	NULL
protein	NULL
.	NULL

Mutants	NULL
with	NULL
alterations	NULL
of	NULL
the	NULL
E2A	NULL
component	NULL
but	NULL
an	NULL
in-tact	NULL
,	NULL
functional	NULL
HLF	NULL
segment	NULL
produced	NULL
a	NULL
different	NULL
pattern	NULL
of	NULL
cell	NULL
survival	NULL
.	NULL

Those	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
AD1	NULL
domain	NULL
,	NULL
either	NULL
a	NULL
complete	NULL
deletion	NULL
(	NULL
A1l-142	NULL
)	NULL
or	NULL
inactivating	NULL
point	NULL
mutations	NULL
(	NULL
19L-R,22F-R	NULL
)	NULL
,	NULL
were	NULL
unable	NULL
to	NULL
promote	NULL
cell	NULL
survival	NULL
despite	NULL
retaining	NULL
a	NULL
functional	NULL
AD2	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
mutants	NULL
with	NULL
deletions	NULL
of	NULL
amino	NULL
acids	NULL
between	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
regions	NULL
,	NULL
in	NULL
the	NULL
AD2	NULL
region	NULL
itself	NULL
,	NULL
and	NULL
in	NULL
regions	NULL
distal	NULL
to	NULL
AD2	NULL
were	NULL
also	NULL
markedly	NULL
compromised	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
enhance	NULL
cell	NULL
survival	NULL
,	NULL
even	NULL
though	NULL
each	NULL
deletion	NULL
mutant	NULL
could	NULL
block	NULL
cell	NULL
death	NULL
when	NULL
the	NULL
HLF	NULL
DNA-binding	NULL
domain	NULL
was	NULL
defective	NULL
.	NULL

As	NULL
with	NULL
similar	NULL
constructs	NULL
lacking	NULL
a	NULL
functional	NULL
DNA-binding	NULL
domain	NULL
,	NULL
abrogation	NULL
of	NULL
the	NULL
transactivating	NULL
function	NULL
of	NULL
both	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
resulted	NULL
in	NULL
a	NULL
mutant	NULL
protein	NULL
that	NULL
could	NULL
not	NULL
prolong	NULL
cell	NULL
survival	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
through	NULL
the	NULL
wild-type	NULL
HLF	NULL
basic	NULL
region	NULL
,	NULL
both	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
,	NULL
as	NULL
well	NULL
as	NULL
their	NULL
intervening	NULL
sequences	NULL
,	NULL
had	NULL
to	NULL
be	NULL
intact	NULL
to	NULL
produce	NULL
a	NULL
significant	NULL
antiapoptotic	NULL
effect	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
with	NULL
mutants	NULL
lacking	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
,	NULL
either	NULL
transactivating	NULL
domain	NULL
was	NULL
adequate	NULL
to	NULL
protect	NULL
cells	NULL
from	NULL
apoptosis	NULL
due	NULL
to	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
intact	NULL
and	NULL
altered	NULL
E2A-HLF	NULL
polypeptides	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
6040	NULL
INUKAI	NULL
ET	NULL
AL	NULL
.	NULL

essential	NULL
for	NULL
their	NULL
function	NULL
in	NULL
gene	NULL
regulation	NULL
(	NULL
13	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
possibility	NULL
that	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
E2A	NULL
and/or	NULL
HLF	NULL
sequences	NULL
affected	NULL
the	NULL
subcellular	NULL
localization	NULL
(	NULL
hence	NULL
the	NULL
antiapoptotic	NULL
properties	NULL
)	NULL
of	NULL
our	NULL
mutants	NULL
,	NULL
we	NULL
studied	NULL
FLS.12	NULL
cells	NULL
by	NULL
immunofluorescence	NULL
,	NULL
using	NULL
antisera	NULL
specific	NULL
for	NULL
E2A	NULL
and	NULL
HLF	NULL
epitopes	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
intact	NULL
E2A-HLF	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
G	NULL
)	NULL
,	NULL
normal	NULL
EZ2A	NULL
(	NULL
E12	NULL
[	NULL
Fig	NULL
.	NULL

5HJ	NULL
and	NULL
E47	NULL
[	NULL
Fig	NULL
.	NULL

51J	NULL
)	NULL
,	NULL
and	NULL
normal	NULL
HLF	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
proteins	NULL
were	NULL
all	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
E2A-HLF	NULL
mutants	NULL
prepared	NULL
in	NULL
this	NULL
study	NULL
was	NULL
also	NULL
targeted	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
shown	NULL
for	NULL
the	NULL
representative	NULL
mutants	NULL
EZA-HLF/BX	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
A1-142	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
)	NULL
,	NULL
and	NULL
A484-574	NULL
(	NULL
Fig	NULL
.	NULL

5J	NULL
)	NULL
,	NULL
whereas	NULL
cells	NULL
transduced	NULL
with	NULL
an	NULL
empty	NULL
vector	NULL
did	NULL
not	NULL
show	NULL
evidence	NULL
of	NULL
staining	NULL
with	NULL
these	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
F	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
all	NULL
polypeptides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
whether	NULL
intact	NULL
or	NULL
modified	NULL
)	NULL
functioned	NULL
as	NULL
nuclear	NULL
proteins	NULL
,	NULL
as	NULL
one	NULL
would	NULL
predict	NULL
from	NULL
their	NULL
nuclear	NULL
localization	NULL
signal	NULL
in	NULL
the	NULL
amino-terminal	NULL
segment	NULL
of	NULL
EZA	NULL
(	NULL
amino	NULL
acids	NULL
170	NULL
to	NULL
175	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
earlier	NULL
studies	NULL
,	NULL
E2A-HLF	NULL
blocked	NULL
apoptosis	NULL
in	NULL
murine	NULL
pro-B	NULL
lymphocytes	NULL
(	NULL
26	NULL
)	NULL
,	NULL
but	NULL
the	NULL
structural	NULL
motifs	NULL
that	NULL
were	NULL
essential	NULL
for	NULL
this	NULL
activity	NULL
remained	NULL
unclear	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
in	NULL
mutants	NULL
bearing	NULL
a	NULL
disabled	NULL
HLF	NULL
basic	NULL
region	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
transactivation	NULL
region	NULL
in	NULL
the	NULL
EZA	NULL
amino-terminal	NULL
segment	NULL
(	NULL
AD1	NULL
or	NULL
AD2	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
rescue	NULL
pro-B	NULL
lymphocytes	NULL
from	NULL
apoptosis	NULL
triggered	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
these	NULL
domains	NULL
in	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
polypeptides	NULL
containing	NULL
the	NULL
amino-terminal	NULL
sequences	NULL
of	NULL
EZ2A	NULL
was	NULL
apparent	NULL
from	NULL
experiments	NULL
in	NULL
which	NULL
specific	NULL
point	NULL
mutations	NULL
that	NULL
abolished	NULL
the	NULL
transactivating	NULL
capacity	NULL
of	NULL
AD1	NULL
and	NULL
AD2	NULL
(	NULL
37	NULL
,	NULL
48	NULL
)	NULL
also	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
mutants	NULL
to	NULL
block	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Neither	NULL
wild-type	NULL
E47	NULL
nor	NULL
wild-type	NULL
E12	NULL
protein	NULL
was	NULL
capable	NULL
of	NULL
mediating	NULL
survival	NULL
when	NULL
overexpressed	NULL
in	NULL
FL5.12	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
amino-terminal	NULL
E2A	NULL
sequences	NULL
have	NULL
antiapoptotic	NULL
activity	NULL
only	NULL
when	NULL
they	NULL
are	NULL
expressed	NULL
outside	NULL
the	NULL
context	NULL
of	NULL
their	NULL
normal	NULL
linkage	NULL
to	NULL
the	NULL
bHLH	NULL
domain	NULL
.	NULL

Thus	NULL
,	NULL
E2A-HLF	NULL
appears	NULL
able	NULL
to	NULL
prevent	NULL
apoptosis	NULL
through	NULL
a	NULL
mechanism	NULL
that	NULL
depends	NULL
critically	NULL
on	NULL
the	NULL
AD1	NULL
and	NULL
AD2Z	NULL
domains	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
mediated	NULL
by	NULL
the	NULL
HLF	NULL
bZIP	NULL
domain	NULL
.	NULL

Exactly	NULL
how	NULL
the	NULL
AD1	NULL
and	NULL
AD2Z	NULL
motifs	NULL
contribute	NULL
to	NULL
the	NULL
antiapoptotic	NULL
effects	NULL
of	NULL
E2A-HLF	NULL
is	NULL
unclear	NULL
,	NULL
although	NULL
two	NULL
mechanisms	NULL
seem	NULL
plausible	NULL
.	NULL

We	NULL
favor	NULL
a	NULL
model	NULL
in	NULL
which	NULL
these	NULL
transactivation	NULL
domains	NULL
are	NULL
guided	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
downstream	NULL
genes	NULL
through	NULL
protein-protein	NULL
interactions	NULL
mediated	NULL
by	NULL
sequences	NULL
within	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
E2A	NULL
,	NULL
allowing	NULL
the	NULL
chimera	NULL
to	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
.	NULL

Precedents	NULL
for	NULL
functional	NULL
activity	NULL
of	NULL
mutant	NULL
transcription	NULL
factors	NULL
lacking	NULL
DNA-binding	NULL
domains	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
Fushi	NULL
tarazu	NULL
(	NULL
Ftz	NULL
)	NULL
Drosophila	NULL
homeodomain	NULL
protein	NULL
and	NULL
the	NULL
glu-cocorticoid	NULL
and	NULL
estrogen	NULL
receptors	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Most	NULL
pertinent	NULL
to	NULL
the	NULL
present	NULL
study	NULL
are	NULL
results	NULL
of	NULL
mutational	NULL
analyses	NULL
showing	NULL
that	NULL
DNA	NULL
binding	NULL
is	NULL
not	NULL
required	NULL
for	NULL
transformation	NULL
mediated	NULL
by	NULL
the	NULL
chimeric	NULL
transcription	NULL
factor	NULL
EZA-PBX1	NULL
(	NULL
9	NULL
,	NULL
30	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
above	NULL
cases	NULL
,	NULL
amino	NULL
acids	NULL
adjacent	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
appeared	NULL
to	NULL
mediate	NULL
protein-protein	NULL
interactions	NULL
that	NULL
allowed	NULL
the	NULL
mutant	NULL
transcription	NULL
factor	NULL
to	NULL
function	NULL
as	NULL
a	NULL
coactivator	NULL
or	NULL
corepressor	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
suspect	NULL
that	NULL
a	NULL
similar	NULL
mechanism	NULL
enables	NULL
EZA	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
when	NULL
its	NULL
HLF	NULL
partner	NULL
lacks	NULL
a	NULL
functional	NULL
bZIP	NULL
domain	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
effects	NULL
we	NULL
observed	NULL
may	NULL
involve	NULL
competition	NULL
by	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
of	NULL
E2A	NULL
for	NULL
transcriptional	NULL
cofactors	NULL
or	NULL
adaptors	NULL
that	NULL
are	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
cell	NULL
death	NULL
programs	NULL
of	NULL
early	NULL
B	NULL
cells	NULL
.	NULL

Examples	NULL
of	NULL
the	NULL
biologic	NULL
activity	NULL
of	NULL
EZA	NULL
transactivator	NULL
regions	NULL
include	NULL
overexpression	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

of	NULL
a	NULL
GALA4-AD1	NULL
chimera	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
slow-growth	NULL
phenotype	NULL
in	NULL
yeast	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AD1	NULL
sequences	NULL
can	NULL
produce	NULL
functionally	NULL
significant	NULL
phenotypic	NULL
changes	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
bHLH-mediated	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
E2A	NULL
amino-terminal	NULL
region	NULL
caused	NULL
cell	NULL
cycle	NULL
arrest	NULL
when	NULL
overexpressed	NULL
in	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
(	NULL
47	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
these	NULL
cells	NULL
it	NULL
can	NULL
interact	NULL
with	NULL
and	NULL
neutralize	NULL
transcriptional	NULL
cofactors	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
prolif-eration	NULL
.	NULL

Further	NULL
study	NULL
of	NULL
downstream	NULL
effectors	NULL
of	NULL
EZA-HLF	NULL
antiapoptotic	NULL
activity	NULL
is	NULL
needed	NULL
to	NULL
distinguish	NULL
between	NULL
these	NULL
two	NULL
possibilities	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
E2A-HLF	NULL
in	NULL
this	NULL
study	NULL
contrast	NULL
sharply	NULL
with	NULL
those	NULL
previously	NULL
ascribed	NULL
to	NULL
EZ2A-PBX1	NULL
,	NULL
which	NULL
is	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
in	NULL
childhood	NULL
pre-B-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Unlike	NULL
our	NULL
experience	NULL
with	NULL
E2A-HLF	NULL
,	NULL
attempts	NULL
to	NULL
constitutively	NULL
express	NULL
E2A-PBX1	NULL
in	NULL
lymphoid	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
unsuccessful	NULL
,	NULL
and	NULL
in	NULL
conditional	NULL
systems	NULL
the	NULL
chimeric	NULL
protein	NULL
induced	NULL
(	NULL
rather	NULL
than	NULL
blocked	NULL
)	NULL
apoptosis	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
E2A-PBX1	NULL
caused	NULL
profound	NULL
deficiencies	NULL
of	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
and	NULL
rendered	NULL
thymocytes	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
activities	NULL
resemble	NULL
those	NULL
of	NULL
the	NULL
Myc	NULL
oncoprotein	NULL
,	NULL
which	NULL
mediates	NULL
both	NULL
programmed	NULL
cell	NULL
death	NULL
and	NULL
malignant	NULL
transformation	NULL
in	NULL
susceptible	NULL
lymphoid	NULL
progenitors	NULL
(	NULL
3	NULL
,	NULL
16	NULL
,	NULL
32	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
apoptotic	NULL
activity	NULL
of	NULL
conditional	NULL
E2A-PBX1	NULL
expression	NULL
in	NULL
hematopoietic	NULL
precursors	NULL
required	NULL
both	NULL
the	NULL
PBX1	NULL
homeodomain	NULL
and	NULL
the	NULL
12	NULL
flanking	NULL
amino	NULL
acids	NULL
that	NULL
form	NULL
the	NULL
HOX	NULL
cooperativity	NULL
motif	NULL
(	NULL
52	NULL
)	NULL
,	NULL
which	NULL
mediates	NULL
interactions	NULL
between	NULL
PBX1	NULL
and	NULL
the	NULL
major	NULL
HOX	NULL
proteins	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
36	NULL
,	NULL
44	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
a	NULL
mutant	NULL
lacking	NULL
all	NULL
PBX1-derived	NULL
sequences	NULL
and	NULL
consisting	NULL
solely	NULL
of	NULL
the	NULL
E2A	NULL
portion	NULL
of	NULL
the	NULL
chimera	NULL
was	NULL
incapable	NULL
of	NULL
inducing	NULL
apoptosis	NULL
(	NULL
52	NULL
)	NULL
.	NULL

How	NULL
,	NULL
then	NULL
,	NULL
does	NULL
one	NULL
account	NULL
for	NULL
the	NULL
very	NULL
different	NULL
effects	NULL
of	NULL
the	NULL
EZA-PBX1	NULL
and	NULL
E2A-HLF	NULL
chimeras	NULL
on	NULL
cell	NULL
sur-vival	NULL
?	NULL

Most	NULL
likely	NULL
,	NULL
the	NULL
cooperative	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
PBX1	NULL
homeodomain	NULL
and	NULL
the	NULL
HOX	NULL
cooperativity	NULL
motif	NULL
positions	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
near	NULL
genes	NULL
whose	NULL
expression	NULL
can	NULL
upregulate	NULL
a	NULL
p53-independent	NULL
apoptotic	NULL
pathway	NULL
(	NULL
52	NULL
)	NULL
.	NULL

We	NULL
have	NULL
proposed	NULL
that	NULL
E2A-HLF	NULL
blocks	NULL
apoptosis	NULL
in	NULL
pro-B	NULL
lymphocytes	NULL
by	NULL
disrupting	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
pathway	NULL
analogous	NULL
to	NULL
the	NULL
cell	NULL
death	NULL
program	NULL
mediated	NULL
by	NULL
ces-2	NULL
,	NULL
the	NULL
C.	NULL
elegans	NULL
ortholog	NULL
of	NULL
HLF	NULL
(	NULL
26	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
chimeric	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
compete	NULL
with	NULL
a	NULL
mammalian	NULL
CES-2-like	NULL
transcription	NULL
factor	NULL
for	NULL
a	NULL
common	NULL
promoter	NULL
binding	NULL
site	NULL
and	NULL
to	NULL
trans-activate	NULL
(	NULL
rather	NULL
than	NULL
repress	NULL
)	NULL
a	NULL
ces-7-like	NULL
gene	NULL
,	NULL
preventing	NULL
the	NULL
death	NULL
of	NULL
pro-B	NULL
cells	NULL
that	NULL
otherwise	NULL
would	NULL
be	NULL
targeted	NULL
for	NULL
de-struction	NULL
.	NULL

Our	NULL
findings	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
in	NULL
which	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
of	NULL
EZ2A	NULL
were	NULL
sufficient	NULL
to	NULL
suppress	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
cell	NULL
death	NULL
program	NULL
in	NULL
growth	NULL
factor-dependent	NULL
pro-B	NULL
lymphocytes	NULL
,	NULL
precluded	NULL
analysis	NULL
of	NULL
additional	NULL
contributions	NULL
mediated	NULL
through	NULL
the	NULL
bZIP	NULL
domain	NULL
of	NULL
HLF	NULL
.	NULL

Evidence	NULL
that	NULL
such	NULL
activity	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
overall	NULL
oncogenic	NULL
effect	NULL
of	NULL
E2A-HLF	NULL
comes	NULL
from	NULL
studies	NULL
of	NULL
NFIL3/EABP4	NULL
,	NULL
a	NULL
growth	NULL
factor-regulated	NULL
bZIP	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
sequence	NULL
in	NULL
FL5.12	NULL
cells	NULL
and	NULL
blocks	NULL
apoptosis	NULL
when	NULL
its	NULL
expression	NULL
is	NULL
enforced	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-3	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TEF	NULL
,	NULL
a	NULL
closer	NULL
relative	NULL
of	NULL
HLF	NULL
and	NULL
potent	NULL
transactivator	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
multiple	NULL
cell	NULL
lines	NULL
(	NULL
15	NULL
,	NULL
23	NULL
)	NULL
,	NULL
efficiently	NULL
mediated	NULL
cell	NULL
survival	NULL
after	NULL
IL-3	NULL
withdrawal	NULL
in	NULL
our	NULL
experimental	NULL
system	NULL
(	NULL
29a	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
TEF	NULL
mutants	NULL
with	NULL
alterations	NULL
in	NULL
the	NULL
bZIP	NULL
basic	NULL
region	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
BX	NULL
mutants	NULL
of	NULL
E2A-HLF	NULL
in	NULL
the	NULL
present	NULL
study	NULL
were	NULL
unable	NULL
to	NULL
block	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
because	NULL
TEF	NULL
lacks	NULL
amino	NULL
acid	NULL
regions	NULL
with	NULL
sequence	NULL
homology	NULL
to	NULL
the	NULL
AD1	NULL
and	NULL
AD2Z	NULL
domains	NULL
of	NULL
the	NULL
EZA	NULL
protein	NULL
and	NULL
interacts	NULL
with	NULL
DNA	NULL
through	NULL
a	NULL
highly	NULL
conserved	NULL
bZIP	NULL
region	NULL
shared	NULL
with	NULL
HLF	NULL
and	NULL
CES-2	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
promote	NULL
the	NULL
survival	NULL
of	NULL
pro-B	NULL
cells	NULL
likely	NULL
depends	NULL
on	NULL
inappropriate	NULL
trans-	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
E2A-HLF	NULL
,	NULL
HLF	NULL
,	NULL
E2A	NULL
,	NULL
and	NULL
representative	NULL
mutant	NULL
proteins	NULL
.	NULL

FL5.12	NULL
cells	NULL
expressing	NULL
each	NULL
construct	NULL
were	NULL
immunostained	NULL
with	NULL
either	NULL
IgG-purified	NULL
anti-HLF	NULL
(	NULL
C	NULL
)	NULL
serum	NULL
(	NULL
A	NULL
to	NULL
E	NULL
)	NULL
or	NULL
the	NULL
anti-E2A	NULL
serum	NULL
(	NULL
F	NULL
to	NULL
J	NULL
)	NULL
.	NULL

Simultaneous	NULL
staining	NULL
with	NULL
DAPI	NULL
was	NULL
performed	NULL
to	NULL
permit	NULL
visualization	NULL
of	NULL
cell	NULL
nuclei	NULL
(	NULL
A	NULL
'	NULL
to	NULL
J	NULL
'	NULL
)	NULL
.	NULL

The	NULL
FL5.12	NULL
cells	NULL
studied	NULL
either	NULL
contained	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
A	NULL
,	NULL
A	NULL
'	NULL
,	NULL
F	NULL
,	NULL
and	NULL
F	NULL
'	NULL
)	NULL
or	NULL
expressed	NULL
E2A-HLF	NULL
(	NULL
B	NULL
,	NULL
B	NULL
'	NULL
,	NULL
G	NULL
,	NULL
and	NULL
G	NULL
'	NULL
)	NULL
,	NULL
HLF	NULL
(	NULL
C	NULL
and	NULL
C	NULL
'	NULL
)	NULL
,	NULL
E2A-HLFE/BX	NULL
(	NULL
D	NULL
and	NULL
D	NULL
'	NULL
)	NULL
,	NULL
A1-142	NULL
(	NULL
E	NULL
and	NULL
E	NULL
'	NULL
)	NULL
,	NULL
E2A	NULL
(	NULL
E12	NULL
)	NULL
(	NULL
H	NULL
and	NULL
H	NULL
'	NULL
)	NULL
,	NULL
E2A	NULL
(	NULL
E47	NULL
)	NULL
(	NULL
I	NULL
and	NULL
I	NULL
'	NULL
)	NULL
,	NULL
or	NULL
A484-574	NULL
(	NULL
J	NULL
and	NULL
J	NULL
'	NULL
)	NULL
.	NULL

6041	NULL
6042	NULL
INUKAI	NULL
ET	NULL
AL	NULL
.	NULL

activation	NULL
of	NULL
downstream	NULL
responder	NULL
genes	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
each	NULL
case	NULL
of	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
pro-B	NULL
leukemia	NULL
studied	NULL
to	NULL
date	NULL
,	NULL
HLF	NULL
sequences	NULL
are	NULL
fused	NULL
in	NULL
frame	NULL
with	NULL
amino-terminal	NULL
EZA	NULL
sequences	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
this	NULL
occurs	NULL
through	NULL
a	NULL
direct	NULL
in-frame	NULL
joining	NULL
of	NULL
£24	NULL
exon	NULL
12	NULL
with	NULL
HLF	NULL
exon	NULL
4	NULL
(	NULL
type	NULL
II	NULL
fusions	NULL
[	NULL
22	NULL
]	NULL
)	NULL
.	NULL

In	NULL
other	NULL
cases	NULL
,	NULL
however	NULL
,	NULL
£24	NULL
exon	NULL
13	NULL
is	NULL
joined	NULL
with	NULL
HLF	NULL
exon	NULL
4	NULL
,	NULL
which	NULL
are	NULL
in	NULL
different	NULL
translational	NULL
reading	NULL
frames	NULL
(	NULL
type	NULL
I	NULL
fusions	NULL
[	NULL
21	NULL
,	NULL
22	NULL
,	NULL
24	NULL
,	NULL
27	NULL
]	NULL
)	NULL
.	NULL

In	NULL
these	NULL
leukemias	NULL
,	NULL
the	NULL
reading	NULL
frame	NULL
is	NULL
restored	NULL
by	NULL
a	NULL
complex	NULL
joining	NULL
exon	NULL
,	NULL
which	NULL
contains	NULL
intronic	NULL
sequences	NULL
from	NULL
both	NULL
the	NULL
£24	NULL
and	NULL
HLF	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
N-region	NULL
nucleotides	NULL
inserted	NULL
at	NULL
the	NULL
breakpoints	NULL
of	NULL
the	NULL
fused	NULL
chromosome	NULL
.	NULL

Consistent	NULL
preservation	NULL
of	NULL
the	NULL
reading	NULL
frame	NULL
linking	NULL
the	NULL
AD1	NULL
and	NULL
AD2	NULL
domains	NULL
of	NULL
E2A	NULL
with	NULL
the	NULL
bZIP	NULL
DNA-binding	NULL
and	NULL
protein	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
in	NULL
leukemogenic	NULL
E2A-HLF	NULL
fusion	NULL
proteins	NULL
indicates	NULL
essential	NULL
roles	NULL
for	NULL
both	NULL
components	NULL
in	NULL
the	NULL
oncogenic	NULL
activity	NULL
of	NULL
the	NULL
chimera	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
E2A-HLF	NULL
possesses	NULL
a	NULL
dual	NULL
capacity	NULL
to	NULL
block	NULL
apoptosis	NULL
,	NULL
one	NULL
depending	NULL
on	NULL
protein-protein	NULL
interactions	NULL
mediated	NULL
by	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
EZ2A	NULL
and	NULL
the	NULL
other	NULL
depending	NULL
on	NULL
classical	NULL
transcriptional	NULL
regulation	NULL
through	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
.	NULL

Such	NULL
versatility	NULL
is	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
enormous	NULL
selection	NULL
pressure	NULL
to	NULL
generate	NULL
fusion	NULL
proteins	NULL
that	NULL
drive	NULL
leukemic	NULL
transformation	NULL
with	NULL
maximum	NULL
effi-ciency	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
F.	NULL
Rauscher	NULL
III	NULL
for	NULL
providing	NULL
the	NULL
pMT-CB6+	NULL
expression	NULL
vector	NULL
,	NULL
C.	NULL
Murre	NULL
for	NULL
the	NULL
E12	NULL
and	NULL
E47	NULL
cDNA	NULL
clones	NULL
,	NULL
A.	NULL
Inoue	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
figures	NULL
,	NULL
and	NULL
J.	NULL
Gilbert	NULL
for	NULL
scientific	NULL
editing	NULL
and	NULL
critical	NULL
comments	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
CA	NULL
59571	NULL
,	NULL
CA	NULL
20180	NULL
,	NULL
and	NULL
Cancer	NULL
Center	NULL
Core	NULL
CA	NULL
21765	NULL
)	NULL
and	NULL
by	NULL
the	NULL
American	NULL
Lebanese	NULL
Syrian	NULL
Associated	NULL
Charities	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adler	NULL
,	NULL
S.	NULL
M.	NULL
L.	NULL
,	NULL
M.	NULL
L.	NULL
Waterman	NULL
,	NULL
X	NULL
.	NULL

He	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1988	NULL
.	NULL

Steroid	NULL
receptor-mediated	NULL
inhibition	NULL
of	NULL
rat	NULL
prolactin	NULL
gene	NULL
expression	NULL
does	NULL
not	NULL
require	NULL
the	NULL
receptor	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Cell	NULL
52:685-695	NULL
.	NULL

2	NULL
.	NULL

Ananthan	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Baler	NULL
,	NULL
D.	NULL
Morrissey	NULL
,	NULL
J.	NULL
Zuo	NULL
,	NULL
Y.	NULL
Lan	NULL
,	NULL
M.	NULL
Weir	NULL
,	NULL
and	NULL
R.	NULL
Voellmy	NULL
.	NULL

1993	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
transcription	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
Drosophila	NULL
fushi	NULL
tarazu	NULL
homeoprotein	NULL
and	NULL
can	NULL
occur	NULL
without	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1599-1609	NULL
.	NULL

3	NULL
.	NULL

Askew	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
R.	NULL
A.	NULL
Ashmun	NULL
,	NULL
B.	NULL
C.	NULL
Simmons	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cleveland	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
c-myc	NULL
expression	NULL
in	NULL
an	NULL
IL-3-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
suppresses	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
accelerates	NULL
apoptosis	NULL
.	NULL

Oncogene	NULL
6:1915-1922	NULL
.	NULL

4	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
Robanus-Maandag	NULL
,	NULL
D.	NULL
J.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
B.	NULL
C.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
H.	NULL
P.	NULL
J.	NULL
te	NULL
Riele	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B-cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

5	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
H.	NULL
P.	NULL
te	NULL
Riele	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
A.	NULL
Sheehy	NULL
,	NULL
M.	NULL
Schlissel	NULL
,	NULL
S.	NULL
A.	NULL
Shinton	NULL
,	NULL
R.	NULL
R.	NULL
Hardy	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1997	NULL
.	NULL

Both	NULL
E12	NULL
and	NULL
E47	NULL
allow	NULL
commitment	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
.	NULL

Immunity	NULL
6:145-154	NULL
.	NULL

6	NULL
.	NULL

Bakhshi	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
Jensen	NULL
,	NULL
P.	NULL
Goldman	NULL
,	NULL
J.	NULL
J.	NULL
Wright	NULL
,	NULL
O.	NULL
W.	NULL
McBride	NULL
,	NULL
A.	NULL
L.	NULL
Epstein	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1985	NULL
.	NULL

Cloning	NULL
the	NULL
chromosomal	NULL
breakpoint	NULL
of	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
human	NULL
lymphomas	NULL
:	NULL
clustering	NULL
around	NULL
JH	NULL
on	NULL
chromosome	NULL
14	NULL
and	NULL
near	NULL
a	NULL
transcriptional	NULL
unit	NULL
on	NULL
18	NULL
.	NULL

Cell	NULL
41:899-906	NULL
.	NULL

7	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
D.	NULL
L.	NULL
Turner	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
61:49-59	NULL
.	NULL

8	NULL
.	NULL

Chakraborty	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
J.	NULL
Brennan	NULL
,	NULL
L.	NULL
Li	NULL
,	NULL
D.	NULL
Edmondson	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Olson	NULL
.	NULL

1991	NULL
.	NULL

Inefficient	NULL
homooligomerization	NULL
contributes	NULL
to	NULL
the	NULL
dependence	NULL
of	NULL
myogenin	NULL
on	NULL
E2A	NULL
products	NULL
for	NULL
efficient	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3633-3641	NULL
.	NULL

9	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
I	NULL
de	NULL
Vivo	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
Hox	NULL
cooperativity	NULL
motif	NULL
of	NULL
the	NULL
chimeric	NULL
oncoprotein	NULL
EZa-Pbx1	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
onco-genesis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:81-88	NULL
.	NULL

10	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
W.	NULL
F.	NULL
Shen	NULL
,	NULL
S.	NULL
Rozenfeld	NULL
,	NULL
H.	NULL
J.	NULL
Lawrence	NULL
,	NULL
C.	NULL
Largman	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1995	NULL
.	NULL

Pbx	NULL
proteins	NULL
display	NULL
hexapeptide-dependent	NULL
cooperative	NULL
DNA	NULL
binding	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
Hox	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:663-674	NULL
.	NULL

11	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
J.	NULL
Sklar	NULL
.	NULL

1985	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
chromosomal	NULL
breakpoint	NULL
in	NULL
follicular	NULL
lymphoma	NULL
and	NULL
demonstration	NULL
of	NULL
a	NULL
break	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

point-cluster	NULL
region	NULL
near	NULL
a	NULL
transcriptionally	NULL
active	NULL
locus	NULL
on	NULL
chromosome	NULL
18	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:7439-7443	NULL
.	NULL

12	NULL
.	NULL

Cserjesi	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Brown	NULL
,	NULL
K.	NULL
L.	NULL
Ligon	NULL
,	NULL
G.	NULL
E.	NULL
Lyons	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Olson	NULL
.	NULL

1995	NULL
.	NULL

Scleraxis	NULL
:	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
protein	NULL
that	NULL
prefigures	NULL
skeletal	NULL
formation	NULL
during	NULL
mouse	NULL
embryogenesis	NULL
.	NULL

Development	NULL
121:1099-1110	NULL
.	NULL

13	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
1997	NULL
.	NULL

STATs	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

Science	NULL
277:1630-1635	NULL
.	NULL

14	NULL
.	NULL

Dedera	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
E.	NULL
K.	NULL
Waller	NULL
,	NULL
D.	NULL
P.	NULL
LeBrun	NULL
,	NULL
A.	NULL
Sen-Majumdar	NULL
,	NULL
M.	NULL
E.	NULL
Stevens	NULL
,	NULL
G.	NULL
S.	NULL
Barsh	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1993	NULL
.	NULL

Chimeric	NULL
homeobox	NULL
gene	NULL
E2A-PBX1	NULL
induces	NULL
proliferation	NULL
,	NULL
apoptosis	NULL
,	NULL
and	NULL
malignant	NULL
lymphomas	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
74:833-843	NULL
.	NULL

15	NULL
.	NULL

Drolet	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
K.	NULL
M.	NULL
Scully	NULL
,	NULL
D.	NULL
M.	NULL
Simmons	NULL
,	NULL
M.	NULL
Wegner	NULL
,	NULL
K.	NULL
T.	NULL
Chu	NULL
,	NULL
L.	NULL
W.	NULL
Swanson	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1991	NULL
.	NULL

TEF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
expressed	NULL
specifically	NULL
in	NULL
the	NULL
anterior	NULL
pituitary	NULL
during	NULL
embryogenesis	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1739-1753	NULL
.	NULL

16	NULL
.	NULL

Evan	NULL
,	NULL
G.	NULL
L	NULL
,	NULL
A.	NULL
H.	NULL
Wyllie	NULL
,	NULL
C.	NULL
S.	NULL
Gilbert	NULL
,	NULL
T.	NULL
D.	NULL
Littlewood	NULL
,	NULL
H.	NULL
Land	NULL
,	NULL
M.	NULL
Brooks	NULL
,	NULL
C.	NULL
M.	NULL
Waters	NULL
,	NULL
L.	NULL
Z.	NULL
Penn	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Hancock	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
fibroblasts	NULL
by	NULL
c-myc	NULL
protein	NULL
.	NULL

Cell	NULL
69:119-128	NULL
.	NULL

17	NULL
.	NULL

Fitzpatrick	NULL
,	NULL
V.	NULL
D.	NULL
,	NULL
A.	NULL
Percival-Smith	NULL
,	NULL
C.	NULL
J.	NULL
Ingles	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Krause	NULL
.	NULL

1992	NULL
.	NULL

Homeodomain-independent	NULL
activity	NULL
of	NULL
the	NULL
fushi	NULL
terazu	NULL
polypeptide	NULL
in	NULL
Drosophila	NULL
embryos	NULL
.	NULL

Nature	NULL
356:610-612	NULL
.	NULL

18	NULL
.	NULL

Guillemot	NULL
,	NULL
F.	NULL
,	NULL
L.	NULL
C.	NULL
Lo	NULL
,	NULL
J.	NULL
E.	NULL
Johnson	NULL
,	NULL
A.	NULL
Auerbach	NULL
,	NULL
D.	NULL
J.	NULL
Anderson	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Joyner	NULL
.	NULL

1993	NULL
.	NULL

Mammalian	NULL
achaete-scute	NULL
homolog	NULL
1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
early	NULL
development	NULL
of	NULL
olfactory	NULL
and	NULL
autonomic	NULL
neurons	NULL
.	NULL

Cell	NULL
75:463-476	NULL
.	NULL

19	NULL
.	NULL

Hsu	NULL
,	NULL
H.-L.	NULL
,	NULL
J.-T.	NULL
Cheng	NULL
,	NULL
Q.	NULL
Chen	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1991	NULL
.	NULL

Enhancer-binding	NULL
activity	NULL
of	NULL
the	NULL
Tal-1	NULL
oncoprotein	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3037-3042	NULL
.	NULL

20	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
I	NULL
Wadman	NULL
,	NULL
J.	NULL
T.	NULL
Tsan	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
control	NULL
by	NULL
the	NULL
TAL1	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5947-5951	NULL
.	NULL

21	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
1996	NULL
.	NULL

Chromosomal	NULL
translocations	NULL
involving	NULL
the	NULL
£24	NULL
gene	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
clinical	NULL
features	NULL
and	NULL
molecular	NULL
pathogenesis	NULL
.	NULL

Blood	NULL
87:1211-1224	NULL
.	NULL

22	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
P.	NULL
E.	NULL
Devaraj	NULL
,	NULL
L.	NULL
Foroni	NULL
,	NULL
L.	NULL
M.	NULL
Secker-Walker	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
genomic	NULL
rearrangements	NULL
create	NULL
alternative	NULL
E2A-HLF	NULL
fusion	NULL
proteins	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
.	NULL

Blood	NULL
83:2261-2267	NULL
.	NULL

23	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
S.	NULL
Li	NULL
,	NULL
M.	NULL
Z	NULL
.	NULL

Fall	NULL
,	NULL
L.	NULL
Naumovski	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proto-oncogene	NULL
HLF	NULL
and	NULL
the	NULL
related	NULL
basic	NULL
leucine	NULL
zipper	NULL
protein	NULL
TEF	NULL
display	NULL
highly	NULL
similar	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
regulatory	NULL
proper-ties	NULL
.	NULL

Blood	NULL
87:4607-4617	NULL
.	NULL

24	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
K.	NULL
Obyashiki	NULL
,	NULL
K.	NULL
Toyama	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1992	NULL
.	NULL

HIf	NULL
,	NULL
a	NULL
novel	NULL
hepatic	NULL
bZIP	NULL
protein	NULL
,	NULL
shows	NULL
altered	NULL
DNA-binding	NULL
properties	NULL
following	NULL
fusion	NULL
to	NULL
E2A	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1608-1620	NULL
.	NULL

25	NULL
.	NULL

Tkushima	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Inukai	NULL
,	NULL
T.	NULL
Inaba	NULL
,	NULL
S.	NULL
D.	NULL
Nimer	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1997	NULL
.	NULL

Pivotal	NULL
role	NULL
for	NULL
the	NULL
NFIL3/E4BP4	NULL
transcription	NULL
factor	NULL
in	NULL
interleukin	NULL
3-mediated	NULL
survival	NULL
of	NULL
pro-B	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:2609-2614	NULL
.	NULL

26	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Inukai	NULL
,	NULL
T.	NULL
Yoshihara	NULL
,	NULL
H.	NULL
Seyschab	NULL
,	NULL
R.	NULL
A.	NULL
Ashmun	NULL
,	NULL
C.	NULL
E.	NULL
Canman	NULL
,	NULL
S.	NULL
J.	NULL
Laken	NULL
,	NULL
M.	NULL
B.	NULL
Kastan	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1996	NULL
.	NULL

Reversal	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
leukaemia-associated	NULL
EZA-HLF	NULL
chimaeric	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
382:541-544	NULL
.	NULL

27	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
W.	NULL
M.	NULL
Roberts	NULL
,	NULL
L.	NULL
H.	NULL
Shapiro	NULL
,	NULL
K.	NULL
W.	NULL
Jolly	NULL
,	NULL
S.	NULL
C.	NULL
Raimondi	NULL
,	NULL
S.	NULL
D.	NULL
Smith	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1992	NULL
.	NULL

Fusion	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
gene	NULL
HLF	NULL
to	NULL
the	NULL
E2A	NULL
gene	NULL
in	NULL
human	NULL
acute	NULL
B-lineage	NULL
leukemia	NULL
.	NULL

Science	NULL
257:531-534	NULL
.	NULL

28	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
H.	NULL
Shapiro	NULL
,	NULL
T.	NULL
Funabiki	NULL
,	NULL
A.	NULL
E.	NULL
Sinclair	NULL
,	NULL
B.	NULL
G.	NULL
Jones	NULL
,	NULL
R.	NULL
A.	NULL
Ashmun	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1994	NULL
.	NULL

DNA-binding	NULL
specificity	NULL
and	NULL
frems-activating	NULL
potential	NULL
of	NULL
the	NULL
leukemia-associated	NULL
E2A-hepatic	NULL
leukemia	NULL
factor	NULL
fusion	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3403-3413	NULL
.	NULL

29	NULL
.	NULL

Inukai	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Inaba	NULL
,	NULL
T.	NULL
Yoshihara	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1997	NULL
.	NULL

Cell	NULL
transformation	NULL
mediated	NULL
by	NULL
homodimeric	NULL
E2A-HLF	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:1417-1424	NULL
.	NULL

29a.Inukai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

30	NULL
.	NULL

Kamps	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
D.	NULL
D.	NULL
Wright	NULL
,	NULL
and	NULL
Q.	NULL
Lu	NULL
.	NULL

1996	NULL
.	NULL

DNA-binding	NULL
by	NULL
oncoprotein	NULL
E2a-Pbx1	NULL
is	NULL
important	NULL
for	NULL
blocking	NULL
differentiation	NULL
but	NULL
dispensable	NULL
for	NULL
fibro-blast	NULL
transformation	NULL
.	NULL

Oncogene	NULL
12:19-30	NULL
.	NULL

31	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

Bcl-2	NULL
initiates	NULL
a	NULL
new	NULL
category	NULL
of	NULL
oncogenes	NULL
:	NULL
regulators	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Blood	NULL
80:879-886	NULL
.	NULL

32	NULL
.	NULL

Langdon	NULL
,	NULL
W.	NULL
Y.	NULL
,	NULL
A.	NULL
W.	NULL
Harris	NULL
,	NULL
S.	NULL
Cory	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Adams	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
C-myc	NULL
oncogene	NULL
perturbs	NULL
B	NULL
lymphocyte	NULL
development	NULL
in	NULL
Emu-myc	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
47:11-18	NULL
.	NULL

33	NULL
.	NULL

Lassar	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
J.	NULL
N.	NULL
Buskin	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
R.	NULL
L.	NULL
Davis	NULL
,	NULL
S.	NULL
Apone	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1989	NULL
.	NULL

MyoD	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
requiring	NULL
a	NULL
region	NULL
of	NULL
myc	NULL
homology	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
muscle	NULL
creatine	NULL
kinase	NULL
enhancer	NULL
.	NULL

Cell	NULL
58:823-831	NULL
.	NULL

34	NULL
.	NULL

Look	NULL
,	NULL
A.	NULL
T.	NULL
1997	NULL
.	NULL

Oncogenic	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
human	NULL
acute	NULL
leu-kemias	NULL
.	NULL

Science	NULL
278:1059-1064	NULL
.	NULL

35	NULL
.	NULL

Look	NULL
,	NULL
A.	NULL
T.	NULL
1998	NULL
.	NULL

Genes	NULL
altered	NULL
by	NULL
chromosomal	NULL
translocations	NULL
in	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
,	NULL
p.	NULL
109-141	NULL
.	NULL

In	NULL
B.	NULL
Vogelstein	NULL
and	NULL
K.	NULL
W.	NULL
Kinzler	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
The	NULL
genetic	NULL
basis	NULL
of	NULL
human	NULL
disease	NULL
.	NULL

McGraw-Hill	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
36	NULL
.	NULL

Lu	NULL
,	NULL
Q.	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Kamps	NULL
.	NULL

1996	NULL
.	NULL

Structural	NULL
determinants	NULL
within	NULL
Pbx1	NULL
that	NULL
mediate	NULL
cooperative	NULL
DNA	NULL
binding	NULL
with	NULL
pentapeptide-containing	NULL
Hox	NULL
pro	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47.	NULL
teins	NULL
:	NULL
proposal	NULL
for	NULL
a	NULL
model	NULL
of	NULL
a	NULL
Pbx1-Hox-DNA	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1632-1640	NULL
.	NULL

Massari	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
P.	NULL
A.	NULL
Jennings	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
AD1	NULL
transactivation	NULL
domain	NULL
of	NULL
E2A	NULL
contains	NULL
a	NULL
highly	NULL
conserved	NULL
helix	NULL
which	NULL
is	NULL
required	NULL
for	NULL
its	NULL
activity	NULL
in	NULL
both	NULL
Saccharomyces	NULL
cerevisiae	NULL
and	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:121-129	NULL
.	NULL

McKearn	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
J.	NULL
McCubrey	NULL
,	NULL
and	NULL
B.	NULL
Fagg	NULL
.	NULL

1985	NULL
.	NULL

Enrichment	NULL
of	NULL
hematopoietic	NULL
precursor	NULL
cells	NULL
and	NULL
cloning	NULL
of	NULL
multipotential	NULL
B-lymphocyte	NULL
precur-sors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:7414-7418	NULL
.	NULL

Metzstein	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
M.	NULL
O.	NULL
Hengartner	NULL
,	NULL
N.	NULL
Tsung	NULL
,	NULL
R.	NULL
E.	NULL
Ellis	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulator	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
encoded	NULL
by	NULL
Caenorhabditis	NULL
elegans	NULL
gene	NULL
ces-2	NULL
.	NULL

Nature	NULL
382:545-547	NULL
.	NULL

Monica	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
P.	NULL
LeBrun	NULL
,	NULL
D.	NULL
A.	NULL
Dedera	NULL
,	NULL
R.	NULL
Brown	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1994	NULL
.	NULL

Transformation	NULL
properties	NULL
of	NULL
the	NULL
E2A-PBX1	NULL
chimeric	NULL
oncoprotein	NULL
:	NULL
fusion	NULL
with	NULL
E2A	NULL
is	NULL
essential	NULL
,	NULL
but	NULL
the	NULL
PBX1	NULL
homeodomain	NULL
is	NULL
dispensable	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:8304-8314	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Bain	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Van	NULL
Dijk	NULL
,	NULL
I.	NULL
Engel	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Furnari	NULL
,	NULL
M.	NULL
E.	NULL
Massari	NULL
,	NULL
J.	NULL
R.	NULL
Matthews	NULL
,	NULL
M.	NULL
W.	NULL
Quong	NULL
,	NULL
R.	NULL
R.	NULL
Rivera	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Stuiver	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1218:129-135	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
mye	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
H.	NULL
Vaessin	NULL
,	NULL
M.	NULL
Caudy	NULL
,	NULL
L.	NULL
Y.	NULL
Jan	NULL
,	NULL
C.	NULL
V.	NULL
Cabrera	NULL
,	NULL
J.	NULL
N.	NULL
Buskin	NULL
,	NULL
S.	NULL
D.	NULL
Hauschka	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
H.	NULL
Weintraub	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

Interactions	NULL
between	NULL
heterologous	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537-544	NULL
.	NULL

Neuteboom	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
L.	NULL
T.	NULL
Peltenburg	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Van	NULL
Dijk	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
hexapeptide	NULL
LFPWMR	NULL
in	NULL
Hoxb-8	NULL
is	NULL
required	NULL
for	NULL
cooperative	NULL
DNA	NULL
binding	NULL
with	NULL
Pbx1	NULL
and	NULL
Pbx2	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9166-9170	NULL
.	NULL

Nunez	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
London	NULL
,	NULL
D.	NULL
Hockenbery	NULL
,	NULL
M.	NULL
Alexander	NULL
,	NULL
J.	NULL
P.	NULL
McKearn	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1990	NULL
.	NULL

Deregulated	NULL
Bcl-2	NULL
gene	NULL
expression	NULL
selectively	NULL
prolongs	NULL
survival	NULL
of	NULL
growth	NULL
factor-deprived	NULL
hemopoietic	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3602-3610	NULL
.	NULL

Packham	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cleveland	NULL
.	NULL

1995.	NULL
c-Myc	NULL
and	NULL
apoptosis	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1242:11-28	NULL
.	NULL

Peverali	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
T.	NULL
Ramgqvist	NULL
,	NULL
R.	NULL
Saffrich	NULL
,	NULL
R.	NULL
Pepperkok	NULL
,	NULL
M.	NULL
V.	NULL
Barone	NULL
,	NULL
and	NULL
L.	NULL
Philipson	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
G1	NULL
progression	NULL
by	NULL
E2A	NULL
and	NULL
Id	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4291-4301	NULL
.	NULL

ANTIAPOPTOTIC	NULL
ROLE	NULL
OF	NULL
E2A-HLF	NULL
IN	NULL
pro-B	NULL
CELLS	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

6043	NULL
Quong	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
M.	NULL
E.	NULL
Massari	NULL
,	NULL
R.	NULL
Zwart	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
new	NULL
transcriptional-activation	NULL
motif	NULL
restricted	NULL
to	NULL
a	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
is	NULL
functionally	NULL
conserved	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:792-800	NULL
.	NULL

Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
1994	NULL
.	NULL

Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Nature	NULL
372:143-149	NULL
.	NULL

Shen	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1995	NULL
.	NULL

B-cell-specific	NULL
DNA	NULL
binding	NULL
by	NULL
an	NULL
E47	NULL
homodimer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15145184524	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
E.	NULL
L.	NULL
Mayer	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1995	NULL
.	NULL

Absence	NULL
of	NULL
blood	NULL
formation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
T-cell	NULL
leukaemia	NULL
oncoprotein	NULL
tal-1/SCL	NULL
.	NULL

Nature	NULL
373:432-434	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Y.	NULL
Jacobs	NULL
,	NULL
C.	NULL
P.	NULL
Chang	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1997	NULL
.	NULL

Chimeric	NULL
oncoprotein	NULL
EZa-Pbx1	NULL
induces	NULL
apoptosis	NULL
of	NULL
hematopoictic	NULL
cells	NULL
by	NULL
a	NULL
p53-independent	NULL
mechanism	NULL
that	NULL
is	NULL
suppressed	NULL
by	NULL
Bcl-2	NULL
.	NULL

Oncogene	NULL
14:2917-2926	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
in	NULL
the	NULL
pathogenesis	NULL
and	NULL
treatment	NULL
of	NULL
disease	NULL
.	NULL

Science	NULL
267:1456-1462	NULL
.	NULL

Tontonoz	NULL
,	NULL
P.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Kim	NULL
,	NULL
R.	NULL
A.	NULL
Graves	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Spiegelman	NULL
.	NULL

1993	NULL
.	NULL

ADD1	NULL
:	NULL
a	NULL
novel	NULL
helix-loop-helix	NULL
transcription	NULL
factor	NULL
associated	NULL
with	NULL
adipocyte	NULL
determination	NULL
and	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4753-4759	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
Gorham	NULL
,	NULL
J.	NULL
Cossman	NULL
,	NULL
E.	NULL
Jaffe	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Croce	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
chromosome	NULL
translocations	NULL
involved	NULL
in	NULL
B-cell	NULL
neoplasms	NULL
result	NULL
from	NULL
mistakes	NULL
in	NULL
VDJ	NULL
joining	NULL
.	NULL

Science	NULL
229:1390-1393	NULL
.	NULL

Van	NULL
Dijk	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
L.	NULL
T.	NULL
Peltenburg	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1995	NULL
.	NULL

Hox	NULL
gene	NULL
products	NULL
modulate	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
Pbx1	NULL
and	NULL
Pbx2	NULL
.	NULL

Mech	NULL
.	NULL

Dev	NULL
.	NULL

52:99-108	NULL
.	NULL

Vaux	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
S.	NULL
Cory	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Adams	NULL
.	NULL

1988	NULL
.	NULL

Bcl-2	NULL
gene	NULL
promotes	NULL
haemo-poietic	NULL
cell	NULL
survival	NULL
and	NULL
cooperates	NULL
with	NULL
c-myc	NULL
to	NULL
immortalize	NULL
pre-B	NULL
cells	NULL
.	NULL

Nature	NULL
335:440-442	NULL
.	NULL

Voronova	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
F.	NULL
Lee	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
E2A	NULL
and	NULL
tal-1	NULL
helix-loop-helix	NULL
proteins	NULL
associate	NULL
in	NULL
vivo	NULL
and	NULL
are	NULL
modulated	NULL
by	NULL
Id	NULL
proteins	NULL
during	NULL
interleukin	NULL
6-induced	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:5952-5956	NULL
.	NULL

Yang	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
thanatopsis	NULL
:	NULL
a	NULL
discourse	NULL
on	NULL
the	NULL
BCL2	NULL
family	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Blood	NULL
88:386-401	NULL
.	NULL

Yoshihara	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Inaba	NULL
,	NULL
L.	NULL
H.	NULL
Shapiro	NULL
,	NULL
J.	NULL
Kato	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1995	NULL
.	NULL

E2A-HLF-mediated	NULL
cell	NULL
transformation	NULL
requires	NULL
both	NULL
the	NULL
#	NULL
rens-activation	NULL
domain	NULL
of	NULL
E2A	NULL
and	NULL
the	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3247-3255	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B-cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875-884	NULL
.	NULL

